datetime,channel,message_id,url,raw,lm_json
2025-12-11T15:00:01+00:00,@bezrec,6922,https://t.me/bezrec/6922,"Pfizer —Å–∫—É–ø–∞–µ—Ç —Ä–∞–∑—Ä–∞–±–æ—Ç—á–∏–∫–æ–≤ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –¥–ª—è –ª–µ—á–µ–Ω–∏—è –æ–∂–∏—Ä–µ–Ω–∏—è. –§–∞—Ä–º–≥–∏–≥–∞–Ω—Ç ¬´—à–æ–ø–∏—Ç—Å—è¬ª –ø–æ-–∫—Ä—É–ø–Ω–æ–º—É. –ü–æ—Å–ª–µ —Ç–æ–≥–æ, –∫–∞–∫ –µ–º—É —É–¥–∞–ª–æ—Å—å –ø–µ—Ä–µ–∫—É–ø–∏—Ç—å —É Novo Nordisk –∫–æ–º–ø–∞–Ω–∏—é Metsera –∑–∞ $10 –º–ª—Ä–¥ –≤–º–µ—Å—Ç–æ –∏–∑–Ω–∞—á–∞–ª—å–Ω—ã—Ö $7,3 –º–ª—Ä–¥, –∞–º–µ—Ä–∏–∫–∞–Ω—Å–∫–∏–π –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—å –æ–±—Ä–∞—Ç–∏–ª –≤–Ω–∏–º–∞–Ω–∏–µ –Ω–∞ –∫–∏—Ç–∞–π—Å–∫—É—é Yao Pharma (¬´–¥–æ—á–∫–∞¬ª Fosun Pharma). –ü–æ —É—Å–ª–æ–≤–∏—è–º —Å–æ–≥–ª–∞—à–µ–Ω–∏—è, Pfizer –∑–∞–ø–ª–∞—Ç–∏—Ç –¥–æ $2,1 –º–ª—Ä–¥ –∑–∞ —ç–∫—Å–∫–ª—é–∑–∏–≤–Ω—É—é –≥–ª–æ–±–∞–ª—å–Ω—É—é –ª–∏—Ü–µ–Ω–∑–∏—é –Ω–∞ —Ä–∞–∑—Ä–∞–±–æ—Ç–∫—É, –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ –∏ –∫–æ–º–º–µ—Ä—Ü–∏–∞–ª–∏–∑–∞—Ü–∏—é –ø–µ—Ä—Å–ø–µ–∫—Ç–∏–≤–Ω–æ–≥–æ –ø–µ—Ä–æ—Ä–∞–ª—å–Ω–æ–≥–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –¥–ª—è –ª–µ—á–µ–Ω–∏—è –æ–∂–∏—Ä–µ–Ω–∏—è YP05002. –≠—Ç–æ—Ç –∞–≥–æ–Ω–∏—Å—Ç —Ä–µ—Ü–µ–ø—Ç–æ—Ä–∞ GLP-1 —Å–µ–π—á–∞—Å –ø—Ä–æ—Ö–æ–¥–∏—Ç –ø–µ—Ä–≤—É—é —Ñ–∞–∑—É –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö –∏—Å–ø—ã—Ç–∞–Ω–∏–π –≤ –ê–≤—Å—Ç—Ä–∞–ª–∏–∏ –∏ –º–æ–∂–µ—Ç —Å—Ç–∞—Ç—å –Ω–æ–≤—ã–º –¥—Ä–∞–π–≤–µ—Ä–æ–º —Ä–æ—Å—Ç–∞ –¥–ª—è –∞–º–µ—Ä–∏–∫–∞–Ω—Å–∫–æ–π –∫–æ—Ä–ø–æ—Ä–∞—Ü–∏–∏, –æ—Å–æ–±–µ–Ω–Ω–æ —Å —É—á–µ—Ç–æ–º —Ç–æ–≥–æ, —á—Ç–æ –∫–æ–Ω–∫—É—Ä–µ–Ω—Ü–∏—è –Ω–∞ –º–Ω–æ–≥–æ–º–∏–ª–ª–∏–∞—Ä–¥–Ω–æ–º —Ä—ã–Ω–∫–µ –º–µ–¥–∏–∫–∞–º–µ–Ω—Ç–æ–∑–Ω–æ–≥–æ –ø–æ—Ö—É–¥–µ–Ω–∏—è —Å–º–µ—â–∞–µ—Ç—Å—è –≤ —Å—Ç–æ—Ä–æ–Ω—É —Ç–∞–±–ª–µ—Ç–∏—Ä–æ–≤–∞–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤. –ù–æ –Ω–µ –±—É–¥–µ–º –∑–∞–±—ã–≤–∞—Ç—å, —á—Ç–æ –ø–µ—Ä—Å–ø–µ–∫—Ç–∏–≤–Ω—ã–π –∫–∞–Ω–¥–∏–¥–∞—Ç ‚Äî –Ω–µ –≤—Å–µ–≥–¥–∞ —Ä–∞–≤–Ω–æ –±—É–¥—É—â–∏–π –±–ª–æ–∫–±–∞—Å—Ç–µ—Ä. –¢–∞–∫, —É Pfizer –æ–∂–∏–¥–∞–Ω–∏—è –Ω–µ —Å–æ–≤–ø–∞–ª–∏ —Å —Ä–µ–∞–ª—å–Ω–æ—Å—Ç—å—é –æ—Ç–Ω–æ—Å–∏—Ç–µ–ª—å–Ω–æ –¥–∞–Ω—É–≥–ª–∏–ø—Ä–æ–Ω–∞. –§–∞—Ä–º–≥–∏–≥–∞–Ω—Ç –æ—Ç–∫–∞–∑–∞–ª—Å—è –æ—Ç —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–∏ —Å–≤–æ–µ–≥–æ –Ω–∏–∑–∫–æ–º–æ–ª–µ–∫—É–ª—è—Ä–Ω–æ–≥–æ –∞–≥–æ–Ω–∏—Å—Ç–∞ GLP-1, –∫–æ—Ç–æ—Ä—ã–π –¥–æ–ª–∂–µ–Ω –±—ã–ª —Å—Ç–∞—Ç—å –∞–ª—å—Ç–µ—Ä–Ω–∞—Ç–∏–≤–æ–π –û–∑–µ–º–ø–∏–∫—É. –ü—Ä–æ–µ–∫—Ç, —Å—É–ª–∏–≤—à–∏–π –º–∏–ª–ª–∏–∞—Ä–¥—ã, –ø–æ–≥–æ—Ä–µ–ª –Ω–∞ –ø–æ–±–æ—á–∫–∞—Ö. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": true
}"
2025-12-11T11:33:41+00:00,@bezrec,6921,https://t.me/bezrec/6921,"¬´–ò–ø—Å–µ–Ω¬ª –ø—Ä–∏—Å–ª—É—à–∞–ª–∞—Å—å –∫ –§–ê–°. –ú–µ–∂–¥—É–Ω–∞—Ä–æ–¥–Ω–∞—è –±–∏–æ—Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∞—è –∫–æ–º–ø–∞–Ω–∏—è –ø–æ–ª—É—á–∏–ª–∞ –ø—Ä–µ–¥—É–ø—Ä–µ–∂–¥–µ–Ω–∏–µ –æ—Ç –∞–Ω—Ç–∏–º–æ–Ω–æ–ø–æ–ª—å—â–∏–∫–æ–≤ –ø–æ—Å–ª–µ —Ç–æ–≥–æ, –∫–∞–∫ –æ—Ç–∫–∞–∑–∞–ª–∞ ¬´–§–∞—Ä–º-–¢—Ä—ç–π–¥¬ª –≤ –∑–∞–∫–ª—é—á–µ–Ω–∏–∏ –¥–æ–≥–æ–≤–æ—Ä–∞ –ø–æ—Å—Ç–∞–≤–∫–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –°–æ–º–∞—Ç—É–ª–∏–Ω –ê—É—Ç–æ–∂–µ–ª—å, –ö–∞–±–æ–º–µ—Ç–∏–∫—Å –∏ –î–∏—Ñ–µ—Ä–µ–ª–∏–Ω –≤ –æ—Ç–¥–µ–ª—å–Ω—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö —Ñ–æ—Ä–º–∞—Ö. –†–µ–≥—É–ª—è—Ç–æ—Ä –ø–æ—Å—á–∏—Ç–∞–ª, —á—Ç–æ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—å –∑–∞–Ω–∏–º–∞–µ—Ç –¥–æ–º–∏–Ω–∏—Ä—É—é—â–µ–µ –ø–æ–ª–æ–∂–µ–Ω–∏–µ –Ω–∞ —Ä—ã–Ω–∫–µ —Ä–µ–∞–ª–∏–∑–∞—Ü–∏–∏ —ç—Ç–∏—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤, –∞ –≤ –µ–≥–æ –∫–æ–º–º–µ—Ä—á–µ—Å–∫–æ–π –ø–æ–ª–∏—Ç–∏–∫–µ —Å–æ–¥–µ—Ä–∂–∞–ª–∏—Å—å —ç–∫–æ–Ω–æ–º–∏—á–µ—Å–∫–∏ –∏ —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—á–µ—Å–∫–∏ –Ω–µ–æ–±–æ—Å–Ω–æ–≤–∞–Ω–Ω—ã–µ —Ç—Ä–µ–±–æ–≤–∞–Ω–∏—è –∫ –≤—ã—Ä—É—á–∫–µ –ø–æ—Ç–µ–Ω—Ü–∏–∞–ª—å–Ω–æ–≥–æ –¥–µ–ª–æ–≤–æ–≥–æ –ø–∞—Ä—Ç–Ω–µ—Ä–∞. –ù–∞—Ä—É—à–∏—Ç–µ–ª—å —Å–æ–ø—Ä–æ—Ç–∏–≤–ª—è—Ç—å—Å—è –Ω–µ —Å—Ç–∞–ª –∏ –æ—Ç—á–∏—Ç–∞–ª—Å—è –æ–± –∏—Å–ø–æ–ª–Ω–µ–Ω–∏–∏ –ø—Ä–µ–¥—É–ø—Ä–µ–∂–¥–µ–Ω–∏—è: üîΩ—Å–ø–æ—Ä–Ω—ã–µ –ø—É–Ω–∫—Ç—ã –∏—Å–∫–ª—é—á–µ–Ω—ã –∏–∑ –∫–æ–º–º–µ—Ä—á–µ—Å–∫–æ–π –ø–æ–ª–∏—Ç–∏–∫–∏; üîΩ—É –∫–æ–Ω—Ç—Ä–∞–≥–µ–Ω—Ç–∞ –ø–æ–≤—Ç–æ—Ä–Ω–æ –∑–∞–ø—Ä–æ—à–µ–Ω –∞–∫—Ç—É–∞–ª—å–Ω—ã–π –∫–æ–º–ø–ª–µ–∫—Ç –¥–æ–∫—É–º–µ–Ω—Ç–æ–≤ –¥–ª—è –ø–µ—Ä–µ—Å–º–æ—Ç—Ä–∞ —Ä–∞–Ω–µ–µ –ø—Ä–∏–Ω—è—Ç–æ–≥–æ —Ä–µ—à–µ–Ω–∏—è –ø–æ –∑–∞—è–≤–∫–µ –Ω–∞ –Ω–µ–¥–∏—Å–∫—Ä–∏–º–∏–Ω–∞—Ü–∏–æ–Ω–Ω—ã—Ö —É—Å–ª–æ–≤–∏—è—Ö. –†–∞–Ω–µ–µ –§–ê–° –∞–Ω–∞–ª–æ–≥–∏—á–Ω—ã–º –æ–±—Ä–∞–∑–æ–º ¬´–ø–µ—Ä–µ–≤–æ—Å–ø–∏—Ç–∞–ª–∞¬ª —Ä–æ—Å—Å–∏–π—Å–∫—É—é ¬´–¥–æ—á–∫—É¬ª —à–≤–µ–π—Ü–∞—Ä—Å–∫–æ–π Swixx BioPharma. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""sanctions, regulation"",
  ""impact"": ""high"",
  ""english"": ""The Russian Federal Antimonopoly Service (FAS) issued a warning to international pharmaceutical company Ipsen after it refused the contract with Farmitrade for supplying Somatulin Autogen, Cabometix and Diferelin in separate medicinal forms. The regulator considered that the producer occupied a dominant position on the market of these medicines and had economically and technologically unjustified requirements in its commercial policy towards potential business partners. Ipsen did not resist and reported compliance with the warning: ‚ùå disputed points were excluded from the commercial policy; ‚ùå a request was made to the counterparty for an updated set of documents for reconsideration of the previous decision on the application under non-discriminatory conditions. Earlier, FAS similarly 're-educated' the Russian subsidiary of Swiss Swixx BioPharma.""
}"
2025-12-11T08:30:01+00:00,@bezrec,6920,https://t.me/bezrec/6920,"–ü–æ—Å–º–æ—Ç—Ä–µ–ª–∏ –æ—á–µ—Ä–µ–¥–Ω–æ–π –æ—Ç—á—ë—Ç –†–æ—Å—Å—Ç–∞—Ç–∞ –æ –¥–∏–Ω–∞–º–∏–∫–µ —Ü–µ–Ω –Ω–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞. –í –Ω–æ—è–±—Ä–µ 2025 –≥–æ–¥–∞ —Ü–µ–Ω—ã –Ω–∞ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã, –≤—Ö–æ–¥—è—â–∏–µ –≤ –ø–µ—Ä–µ—á–µ–Ω—å –ñ–ù–í–õ–ü, –≤ —Å—Ä–µ–¥–Ω–µ–º –≤—ã—Ä–æ—Å–ª–∏ –Ω–∞ 0,6%: - –±–µ—Ç–∞–ª–æ–∫ –ó–û–ö +4,5%; - –¥–∏–∫–ª–æ—Ñ–µ–Ω–∞–∫ +2,1%; - –Ω–∞—Ç—Ä–∏—è —Ö–ª–æ—Ä–∏–¥ +2%; - –ª–æ–ø–µ—Ä–∞–º–∏–¥ +1,5%; - –∞–º–±—Ä–æ–∫—Å–æ–ª +1,3%; - –ø–µ—Ä–µ–∫–∏—Å—å –≤–æ–¥–æ—Ä–æ–¥–∞ +1,2%. –ù–µ–º–Ω–æ–≥–æ –ø–æ–¥–µ—à–µ–≤–µ–ª–∏ –∞–º–æ–∫—Å–∏—Ü–∏–ª–ª–∏–Ω —Å –∫–ª–∞–≤—É–ª–∞–Ω–æ–≤–æ–π –∫–∏—Å–ª–æ—Ç–æ–π (-1,6%) –∏ —Å—É–ø—Ä–∞—Å—Ç–∏–Ω (-0,5%). –¶–µ–Ω—ã –Ω–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –Ω–µ –∏–∑ –ø–µ—Ä–µ—á–Ω—è –ñ–ù–í–õ–ü, –≤ —Å—Ä–µ–¥–Ω–µ–º –∏–∑–º–µ–Ω–∏–ª–∏—Å—å –Ω–∞ +0,3%: - –≥—Ä–∞–º–º–∏–¥–∏–Ω +1,3%; - –º–µ—Ç–∞–º–∏–∑–æ–ª –Ω–∞—Ç—Ä–∏—è (–∞–Ω–∞–ª—å–≥–∏–Ω –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω—ã–π); - –∫–∞–Ω–µ—Ñ—Ä–æ–Ω –ù –∏ –≤–∞–ª–µ—Ä–∏–∞–Ω—ã —ç–∫—Å—Ç—Ä–∞–∫—Ç +1,0%. –°–Ω–∏–∑–∏–ª–∏—Å—å —Ü–µ–Ω—ã: –Ω–∞ –ø–µ–Ω—Ç–∞–ª–≥–∏–Ω (-0,5%), —Ç—Ä–µ–∫—Ä–µ–∑–∞–Ω –∏ –∫–æ—Ä–≤–∞–ª–æ–ª (-0,3%). ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""reimbursement,pricing,safety"",
  ""impact"": ""medium"",
  ""english"": ""The report from Rosstat shows that in November 2025, the prices of drugs included in the list of essential medicines have risen by an average of 0.6%. The increase is as follows: - Betaloc ZO +4.5%; - Diclofenac +2.1%; - Sodium chloride +2%; - Loperamide +1.5%; - Ambroxol +1.3%; - Hydrogen peroxide +1.2%. Prices of drugs not included in the list have risen by an average of 0.3%, including Gramidin +1.3%; Metamizol sodium (domestic analgin); Kanefron N and valerian extract +1.0%. Prices have decreased: Pentalgin -0.5%, Tricresan and Korvalol -0.3%.""
}"
2025-12-11T05:33:52+00:00,@bezrec,6919,https://t.me/bezrec/6919,"RNC Pharma –ø—Ä–µ–¥—Å—Ç–∞–≤–∏–ª–∞ —Ä–µ–π—Ç–∏–Ω–≥ –∞–ø—Ç–µ—á–Ω—ã—Ö —Å–µ—Ç–µ–π –ø–æ –∏—Ç–æ–≥–∞–º I-III –∫–≤–∞—Ä—Ç–∞–ª–∞ 2025 –≥–æ–¥–∞. –£—Ö–æ–¥—è—â–∏–π –≥–æ–¥ –∑–∞–ø–æ–º–Ω–∏–ª—Å—è —Ñ–∞—Ä–º—Ä–∏—Ç–µ–π–ª—É –¥–≤—É–º—è –≤–∞–∂–Ω—ã–º–∏ —Å–æ–±—ã—Ç–∏—è–º–∏: üíä –î–æ–ª—è –ø–∞—Ä–∞—Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏–∫–∏ –ø–µ—Ä–µ—à–∞–≥–Ω—É–ª–∞ –ø—Å–∏—Ö–æ–ª–æ–≥–∏—á–µ—Å–∫–∏–π –±–∞—Ä—å–µ—Ä –≤ —Å—Ç—Ä—É–∫—Ç—É—Ä–µ –∞–ø—Ç–µ—á–Ω–æ–π –≤—ã—Ä—É—á–∫–∏, –æ–ø—É—Å—Ç–∏–≤—à–∏—Å—å –¥–æ 19,7% (–≤ —Ä—É–±–ª—è—Ö), —Ç–æ–≥–¥–∞ –∫–∞–∫ –µ—â—ë –≤ 2022 –≥–æ–¥—É –æ–Ω–∞ –ø—Ä–µ–≤—ã—à–∞–ª–∞ 24%. –ö–∞—Ç–µ–≥–æ—Ä–∏—è ¬´–ø—Ä–æ—Å–µ–ª–∞¬ª –Ω–∞ 7 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π. üíä –û—Ç—Ä–∞—Å–ª—å –≤—Å—Ç—É–ø–∏–ª–∞ –≤ –ø–µ—Ä–∏–æ–¥ –∫–æ–ª–∏—á–µ—Å—Ç–≤–µ–Ω–Ω–æ–π –¥–µ–≥—Ä–∞–¥–∞—Ü–∏–∏ ‚Äî —á–∏—Å–ª–µ–Ω–Ω–æ—Å—Ç—å –∞–ø—Ç–µ–∫ –≤ —Å—Ç—Ä–∞–Ω–µ —Å–æ–∫—Ä–∞—Ç–∏–ª–∞—Å—å –Ω–∞ 754 —Ç–æ—á–∫–∏, –¥–æ 84,9 —Ç—ã—Å.. –ù–∏–∫–∞–∫–æ–π –ø—Ä–æ–±–ª–µ–º—ã –∞–Ω–∞–ª–∏—Ç–∏–∫–∏ —Ç—É—Ç –Ω–µ –≤–∏–¥—è—Ç ‚Äî –∏–Ω—Ç–µ—Ä–µ—Å–µ–Ω —Å–∞–º —Ñ–∞–∫—Ç –¥–æ—Å—Ç–∏–∂–µ–Ω–∏—è ¬´–ø–æ—Ç–æ–ª–∫–∞¬ª –≤ —Ä–∞–∑–≤–∏—Ç–∏–∏ –∏–Ω—Ñ—Ä–∞—Å—Ç—Ä—É–∫—Ç—É—Ä–Ω–æ–π —Å–æ—Å—Ç–∞–≤–ª—è—é—â–µ–π —Ñ–∞—Ä–º—Ä–∏—Ç–µ–π–ª–∞. –ü—Ä–æ—Ü–µ—Å—Å, –≤ –∑–Ω–∞—á–∏—Ç–µ–ª—å–Ω–æ–π —Å—Ç–µ–ø–µ–Ω–∏ —Å–≤—è–∑–∞–Ω–Ω—ã–π —Å –∏–∑–º–µ–Ω–µ–Ω–∏—è–º–∏ —Ñ–∏—Å–∫–∞–ª—å–Ω–æ–π –ø–æ–ª–∏—Ç–∏–∫–∏, –ø—Ä–æ–¥–æ–ª–∂–∏—Ç—Å—è –∏ –≤ —Å–ª–µ–¥—É—é—â–µ–º –≥–æ–¥—É. –¢–µ–º –±–æ–ª–µ–µ —á—Ç–æ –ø–æ–º–∏–º–æ —Å–Ω–∏–∂–µ–Ω–∏—è –ø–æ—Ä–æ–≥–∞ –¥–ª—è –£–°–ù, –Ω–∞—Å –æ–∂–∏–¥–∞–µ—Ç –µ—â—ë –∏ –ø–æ–≤—ã—à–µ–Ω–∏–µ –ù–î–° –¥–æ 22%. –í –Ω–∞—Å—Ç—É–ø–∞—é—â–µ–º –≥–æ–¥—É —ç–∫—Å–ø–µ—Ä—Ç—ã –ø—Ä–æ–≥–Ω–æ–∑–∏—Ä—É—é—Ç —Ä–∞—Å—à–∏—Ä–µ–Ω–∏–µ –∫–æ–Ω—Å–æ–ª–∏–¥–∞—Ü–∏–æ–Ω–Ω—ã—Ö –ø—Ä–æ—Ü–µ—Å—Å–æ–≤, –≥–¥–µ –æ—Å–Ω–æ–≤–Ω–∞—è —Ä–æ–ª—å –±—É–¥–µ—Ç –æ—Ç–≤–µ–¥–µ–Ω–∞ –Ω–µ –∞—Å—Å–æ—Ü–∏–∞—Ç–∏–≤–Ω—ã–º —Ñ–æ—Ä–º–∞—Ç–∞–º, –∞ M&A-–∞–∫—Ç–∏–≤–Ω–æ—Å—Ç–∏. –í —Ç–æ–ø-10 —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω—ã—Ö –∞–ø—Ç–µ—á–Ω—ã—Ö —Å–µ—Ç–µ–π –ø–æ –∏—Ç–æ–≥–∞–º 9 –º–µ—Å—è—Ü–µ–≤ 2025 –≥–æ–¥–∞ –≤–æ—à–ª–∏: ¬´–†–∏–≥–ª–∞¬ª, ¬´–ê–ø—Ä–µ–ª—å¬ª, –û–ê–° ¬´–≠—Ä–∫–∞—Ñ–∞—Ä–º –∏ –ú–µ–ª–æ–¥–∏—è –ó–¥–æ—Ä–æ–≤—å—è¬ª, ¬´–ò–º–ø–ª–æ–∑–∏—è¬ª, ¬´–í–∏—Ç–∞¬ª, ¬´–ò—Ä–∏—Å¬ª, ¬´–ú–∞–≥–Ω–∏—Ç¬ª, ¬´–ú–∞–∫—Å–∞–≤–∏—Ç¬ª, ¬´–§–∞—Ä–º–∞–∏–º–ø–µ–∫—Å¬ª, ¬´–ê–ª–æ—ç¬ª. –ù–∞ –ø—Ä–æ—à–ª–æ–π –Ω–µ–¥–µ–ª–µ —Å–≤–æ–π —Ä–µ–π—Ç–∏–Ω–≥ –ø—Ä–µ–¥—Å—Ç–∞–≤–∏–ª–∞ DSM Group. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""demand, clinical_trial"",
  ""impact"": ""medium"",
  ""english"": ""RNC Pharma released a ranking of pharmacy chains for the first three quarters of 2025. The year has been marked by two important events in the pharmaceutical retail sector: üíä The share of parapharmacies surpassed the psychological barrier in the structure of pharmacy revenue, dropping to 19.7% (in rubles), while it was above 24% in 2022. This category lost 7 billion rubles. üíä The industry entered a period of quantitative degradation ‚Äî the number of pharmacies in the country decreased by 754 points, reaching 84,9 thousand. No analysts see any problems here ‚Äî what is interesting is the fact that the infrastructure component of pharmaceutical retail has reached its 'ceiling'. This process, to a significant extent, is related to changes in fiscal policy and will continue next year. Moreover, besides reducing the threshold for U.S.N., we are also expecting an increase in VAT to 22%. In the coming year, experts predict the expansion of consolidation processes, where the main role will be assigned not"
2025-12-11T16:46:43+00:00,@medpharm,13985,https://t.me/medpharm/13985,"ü¶æ –ü–æ–¥ –µ–ª–æ—á–∫—É. –í –ú–∏–Ω–∑–¥—Ä–∞–≤–µ –†–§ –ø—Ä–∏–∑–Ω–∞–ª–∏ –ø—Ä–æ–±–ª–µ–º—ã —É —Ä–µ–≥–∏–æ–Ω–æ–≤ —Å –¥–æ—Å—Ç–∏–∂–µ–Ω–∏–µ–º –ø–æ–∫–∞–∑–∞—Ç–µ–ª–µ–π –º–∞–π—Å–∫–∏—Ö —É–∫–∞–∑–æ–≤ –ø–æ –∑–∞—Ä–ø–ª–∞—Ç–∞–º –º–µ–¥—Ä–∞–±–æ—Ç–Ω–∏–∫–æ–≤. –ò—Å–ø—Ä–∞–≤–ª–µ–Ω–∏–µ —Å–∏—Ç—É–∞—Ü–∏–∏ –æ–±–µ—â–∞—é—Ç –≤ –∫–æ–Ω—Ü–µ –≥–æ–¥–∞. ü¶æ –ö—Ç–æ –Ω–∞ –Ω–æ–≤–µ–Ω—å–∫–æ–≥–æ. –°–æ–≥–ª–∞—Å–Ω–æ –ø—Ä–æ–≥–Ω–æ–∑–∞–º –ü—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–∞ –†–§, –≤ 2026 –≥–æ–¥—É –≤ –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã–µ —É—á—Ä–µ–∂–¥–µ–Ω–∏—è –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –ø—Ä–∏–¥–µ—Ç –Ω–∞ —Ä–∞–±–æ—Ç—É –±–æ–ª—å—à–µ 6 —Ç—ã—Å. –≤—Ä–∞—á–µ–π –∏ —Å–≤—ã—à–µ 8 —Ç—ã—Å. —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–æ–≤ —Å—Ä–µ–¥–Ω–µ–≥–æ –∑–≤–µ–Ω–∞. –ù–∞ –æ–ø–ª–∞—Ç—É –∏—Ö —Ç—Ä—É–¥–∞ –±—É–¥–µ—Ç –≤—ã–¥–µ–ª–µ–Ω–æ –¥–æ–ø–æ–ª–Ω–∏—Ç–µ–ª—å–Ω–æ –±–æ–ª–µ–µ 9,6 –º–ª—Ä–¥ —Ä—É–±. ‚ù§Ô∏è –ü—Ä–∏–≤–µ–¥–∏ –¥—Ä—É–≥–∞. –î–µ—Ñ–∏—Ü–∏—Ç –∫–∞–¥—Ä–æ–≤ –∑–∞—Å—Ç–∞–≤–∏–ª —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–∏ –ø–ª–∞—Ç–∏—Ç—å –∑–∞ —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–∏. –ë–æ–Ω—É—Å—ã –≤—ã—Ä–æ—Å–ª–∏ –≤ –æ—Ç–¥–µ–ª—å–Ω—ã—Ö —Å–ª—É—á–∞—è—Ö –¥–æ 80 —Ç—ã—Å. —Ä—É–±. –û —Ç–æ–º, –∫–∞–∫ –∑–∞—Ä–∞–±–æ—Ç–∞—Ç—å –Ω–∞ –¥—Ä—É–∑—å—è—Ö –∏ –∫–∞–∫–∏–µ –Ω–∞–ª–æ–≥–∏ –ø—Ä–µ–¥—Å—Ç–æ–∏—Ç –∑–∞–ø–ª–∞—Ç–∏—Ç—å —Å –ø–æ–ª—É—á–µ–Ω–Ω—ã—Ö –ø—Ä–µ–º–∏–π, –≤—ã—è—Å–Ω–∏–ª ¬´–§–í¬ª. ‚ù§Ô∏è –°—Ç–∞—Ç–∏—Å—Ç–∏–∫–∞. –†–æ—Å—Å—Ç–∞—Ç –æ–ø—É–±–ª–∏–∫–æ–≤–∞–ª –¥–∞–Ω–Ω—ã–µ –æ —Ü–µ–Ω–∞—Ö –Ω–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –≤ –Ω–æ—è–±—Ä–µ. –í—Ç–æ—Ä–æ–π –º–µ—Å—è—Ü —Å–∏–ª—å–Ω–µ–µ –≤—Å–µ–≥–æ –¥–æ—Ä–æ–∂–∞–µ—Ç –±–µ—Ç–∞–ª–æ–∫ –ó–û–ö.","{
  ""skip"": true
}"
2025-12-11T15:39:03+00:00,@medpharm,13984,https://t.me/medpharm/13984,"–í —Ç–µ–∫—É—â–µ–º –≥–æ–¥—É –º–Ω–æ–≥–∏–µ –∫–æ–º–ø–∞–Ω–∏–∏ —É–≤–µ–ª–∏—á–∏–ª–∏ –≤–æ–∑–Ω–∞–≥—Ä–∞–∂–¥–µ–Ω–∏–µ, –≤—ã–ø–ª–∞—á–∏–≤–∞–µ–º–æ–µ –≤ —Ä–∞–º–∫–∞—Ö —Ä–µ—Ñ–µ—Ä–∞–ª—å–Ω—ã—Ö –ø—Ä–æ–≥—Ä–∞–º–º. –ó–∞ –ø—Ä–∏–≤–µ–¥–µ–Ω–Ω–æ–≥–æ –Ω–∞ –≤–∞–∫–∞–Ω—Å–∏—é –¥—Ä—É–≥–∞ —Å–æ—Ç—Ä—É–¥–Ω–∏–∫ —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–∏ –º–æ–∂–µ—Ç –ø–æ–ª—É—á–∏—Ç—å –¥–æ 80 —Ç—ã—Å. —Ä—É–±. –ö–∞–∫ —Ä–∞–±–æ—Ç–∞—é—Ç –ø—Ä–æ–≥—Ä–∞–º–º—ã, –≤—ã—è—Å–Ω–∏–ª ¬´–§–í¬ª. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QnhNT #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ö–∞—Ä—å–µ—Ä–∞","{""skip"": true}"
2025-12-11T15:19:05+00:00,@medpharm,13983,https://t.me/medpharm/13983,"–£—Ç–≤–µ—Ä–∂–¥–µ–Ω—ã –Ω–æ–≤—ã–µ —Å—Ç–∏–º—É–ª–∏—Ä—É—é—â–∏–µ –Ω–∞–¥–±–∞–≤–∫–∏ –¥–ª—è —Å–æ—Ç—Ä—É–¥–Ω–∏–∫–æ–≤, —Ä–∞–±–æ—Ç–∞—é—â–∏—Ö –≤ –º–µ–¥—É—á—Ä–µ–∂–¥–µ–Ω–∏—è—Ö –§–ú–ë–ê –Ω–∞ –ö—Ä–∞–π–Ω–µ–º –°–µ–≤–µ—Ä–µ –∏ –ø—Ä–∏—Ä–∞–≤–Ω–µ–Ω–Ω—ã—Ö —Ä–µ–≥–∏–æ–Ω–∞—Ö. –°—Ä–µ–¥–∏ —É—Å–ª–æ–≤–∏–π –ø–æ–ª—É—á–µ–Ω–∏—è ‚Äî —Ç—Ä—É–¥–æ–≤–æ–π –¥–æ–≥–æ–≤–æ—Ä —Å—Ä–æ–∫–æ–º –º–∏–Ω–∏–º—É–º –Ω–∞ —Ç—Ä–∏ –≥–æ–¥–∞. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QngRW #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{
  ""skip"": false,
  ""country"": ""regional"",
  ""topic"": ""hospital_policy"",
  ""impact"": ""medium"",
  ""english"": ""New bonuses for employees of medical institutions under the FSB have been approved. Conditions include a minimum three-year employment contract. More details: https://clck.ru/3QngRW #MedNews #Healthcare #HealthOrganization""
}"
2025-12-11T14:49:03+00:00,@medpharm,13982,https://t.me/medpharm/13982,–í–∞–∫—Ü–∏–Ω–∞—Ü–∏—è –ø—Ä–æ—Ç–∏–≤ –æ–ø–æ—è—Å—ã–≤–∞—é—â–µ–≥–æ –≥–µ—Ä–ø–µ—Å–∞ –æ–∫–∞–∑–∞–ª–∞—Å—å —Å–≤—è–∑–∞–Ω–∞ —Å–æ —Å–Ω–∏–∂–µ–Ω–∏–µ–º —á–∏—Å–ª–∞ –Ω–æ–≤—ã—Ö —Å–ª—É—á–∞–µ–≤ –¥–µ–º–µ–Ω—Ü–∏–∏ –∏ –ª–µ—Ç–∞–ª—å–Ω—ã—Ö –∏—Å—Ö–æ–¥–æ–≤ —Å—Ä–µ–¥–∏ –ø–æ–∂–∏–ª—ã—Ö –ª—é–¥–µ–π. –ü–æ–ª–æ–∂–∏—Ç–µ–ª—å–Ω—ã–π —ç—Ñ—Ñ–µ–∫—Ç –Ω–∞–±–ª—é–¥–∞–ª—Å—è –¥–∞–∂–µ —É –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å —É–∂–µ —É—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω–Ω—ã–º –¥–∏–∞–≥–Ω–æ–∑–æ–º –¥–µ–º–µ–Ω—Ü–∏–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QnevQ #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–∞–∫—Ç–∏–∫–∞ #–ò–Ω—Ñ–µ–∫—Ü–∏–æ–Ω–Ω—ã–µ_–±–æ–ª–µ–∑–Ω–∏ #–ò–º–º—É–Ω–æ–ª–æ–≥–∏—è_–∏_–∞–ª–ª–µ—Ä–≥–æ–ª–æ–≥–∏—è #–ù–µ–≤—Ä–æ–ª–æ–≥–∏—è #–¢–µ—Ä–∞–ø–∏—è,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""vaccine, epidemic"",
  ""impact"": ""high"",
  ""english"": ""The vaccination against herpes zoster was associated with a reduction in new cases of dementia and mortality among elderly people. A positive effect was observed even in patients already diagnosed with dementia. More information: https://clck.ru/3QnevQ #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–∞–∫—Ç–∏–∫–∞ #–ò–Ω—Ñ–µ–∫—Ü–∏–æ–Ω–Ω—ã–µ_–±–æ–ª–µ–∑–Ω–∏ #–ò–º–º—É–Ω–æ–ª–æ–≥–∏—è_–∏_–∞–ª–ª–µ—Ä–≥–æ–ª–æ–≥–∏—è #–ù–µ–≤—Ä–æ–ª–æ–≥–∏—è #–¢–µ—Ä–∞–ø–∏—è""
}"
2025-12-11T14:19:03+00:00,@medpharm,13981,https://t.me/medpharm/13981,"–§–ê–° –Ω–∞–ø—Ä–∞–≤–∏–ª–∞ –ø–∏—Å—å–º–æ —Ä—É–∫–æ–≤–æ–¥–∏—Ç–µ–ª—è–º —Ç–µ—Ä—Ä–∏—Ç–æ—Ä–∏–∞–ª—å–Ω—ã—Ö –æ—Ä–≥–∞–Ω–æ–≤ –∏ —É—á–∞—Å—Ç–Ω–∏–∫–∞–º –∫–æ–Ω—Ç—Ä–∞–∫—Ç–Ω–æ–π —Å–∏—Å—Ç–µ–º—ã –æ–± –æ—Ç–∑—ã–≤–µ —Å–≤–æ–∏—Ö –ø–∏—Å–µ–º, –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω–Ω—ã—Ö –≤ —è–Ω–≤–∞—Ä–µ 2025 –≥–æ–¥–∞ –∏ –∫–∞—Å–∞—é—â–∏—Ö—Å—è –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ —Å –ú–ù–ù –∞–∫—Å–∏—Ç–∏–Ω–∏–±, –æ—Å–∏–º–µ—Ä—Ç–∏–Ω–∏–±, —Ä—É–∫—Å–æ–ª–∏—Ç–∏–Ω–∏–± –∏ –¥–∞–ø–∞–≥–ª–∏—Ñ–ª–æ–∑–∏–Ω. –¢–æ–≥–¥–∞ –∞–Ω—Ç–∏–º–æ–Ω–æ–ø–æ–ª—å–Ω–∞—è —Å–ª—É–∂–±–∞ –æ–±—Ä–∞—â–∞–ª–∞ –≤–Ω–∏–º–∞–Ω–∏–µ –Ω–∞ —Ç–æ, —á—Ç–æ –Ω–∞–ª–∏—á–∏–µ –≤ –∑–∞—è–≤–∫–∞—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ –∫–æ–º–ø–∞–Ω–∏–∏ ¬´–û–Ω–∫–æ—Ç–∞—Ä–≥–µ—Ç¬ª –Ω–∞—Ä—É—à–∞–µ—Ç –¥–µ–π—Å—Ç–≤—É—é—â–µ–µ –∑–∞–∫–æ–Ω–æ–¥–∞—Ç–µ–ª—å—Å—Ç–≤–æ. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QndCL #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""sanctions, tender"",
  ""impact"": ""high"",
  ""english"": ""The Federal Antimonopoly Service (FAS) has issued a letter to territorial organs and contract system participants regarding the revocation of their letters from January 2025. These letters mentioned drugs with INN acitinib, osimertinib, ruxolitinib, and dapagliflozin produced by 'Onkotarget' company. The FAS previously warned that including these drugs in the application violates current legislation.""
}"
2025-12-11T13:53:02+00:00,@medpharm,13980,https://t.me/medpharm/13980,–í –†–æ—Å—Å–∏–∏ –ø–æ—è–≤–∏—Ç—Å—è —Ä–µ–µ—Å—Ç—Ä –æ —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤–∏–∏ —Ñ–∞—Ä–º–≤—É–∑–æ–≤ —Ç—Ä–µ–±–æ–≤–∞–Ω–∏—è–º –ø—Ä–∞–∫—Ç–∏—á–µ—Å–∫–æ–π –ø–æ–¥–≥–æ—Ç–æ–≤–∫–∏ —Å—Ç—É–¥–µ–Ω—Ç–æ–≤. –ö–∞–∫ –†–æ—Å–∑–¥—Ä–∞–≤–Ω–∞–¥–∑–æ—Ä –±—É–¥–µ—Ç –≤–µ—Å—Ç–∏ —Ä–µ–µ—Å—Ç—Ä? –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QnbPx #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞,"{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""regulation, registration"",
  ""impact"": ""high"",
  ""english"": ""The Russian Health Supervision Agency will be managing a registry of pharmaceutical schools' compliance with practical student training requirements. How the agency plans to manage this registry is discussed in detail.""
}"
2025-12-11T13:41:05+00:00,@medpharm,13979,https://t.me/medpharm/13979,–í –ì–æ—Å–¥—É–º—É –†–§ –≤–Ω–µ—Å–µ–Ω—ã –ø–æ–ø—Ä–∞–≤–∫–∏ –≤ –∑–∞–∫–æ–Ω ¬´–û–± –æ—Å–Ω–æ–≤–Ω—ã—Ö –≥–∞—Ä–∞–Ω—Ç–∏—è—Ö –ø—Ä–∞–≤ —Ä–µ–±–µ–Ω–∫–∞¬ª. –ü—Ä–µ–¥–ª–∞–≥–∞–µ—Ç—Å—è –ø–æ–≤—ã—Å–∏—Ç—å —Å—Ç–∞—Ç—É—Å –º–µ–∂–≤–µ–¥–æ–º—Å—Ç–≤–µ–Ω–Ω—ã—Ö –∫–æ–º–∏—Å—Å–∏–π –ø–æ –≤–æ–ø—Ä–æ—Å–∞–º –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–∏ –æ—Ç–¥—ã—Ö–∞ –∏ –æ–∑–¥–æ—Ä–æ–≤–ª–µ–Ω–∏—è –¥–µ—Ç–µ–π. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QnaiQ #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–î—Ä—É–≥–æ–µ,"{""skip"": true}"
2025-12-11T12:56:04+00:00,@medpharm,13978,https://t.me/medpharm/13978,"–ò–ò –∏—Å–ø–æ–ª—å–∑—É–µ—Ç—Å—è –¥–ª—è —Å–æ–∑–¥–∞–Ω–∏—è –∫–∞–∂–¥–æ–≥–æ —Ç—Ä–µ—Ç—å–µ–≥–æ –Ω–æ–≤–æ–≥–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞, –∞ –∑–∞–Ω–∏–º–∞—é—â–∏–µ—Å—è —ç—Ç–∏–º –µ–≤—Ä–æ–ø–µ–π—Å–∫–∏–µ —Å—Ç–∞—Ä—Ç–∞–ø—ã –ø—Ä–∏–≤–ª–µ–∫–ª–∏ –±–æ–ª–µ–µ 2 –º–ª—Ä–¥ –¥–æ–ª–ª. –∑–∞ 2025 –≥–æ–¥. –û–¥–Ω–∞–∫–æ –∏–Ω–≤–µ—Å—Ç–∏—Ü–∏–∏ —Ä–∞—Å–ø—Ä–µ–¥–µ–ª—è—é—Ç—Å—è –Ω–µ—Ä–∞–≤–Ω–æ–º–µ—Ä–Ω–æ. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QnXZE #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{""skip"": true}"
2025-12-11T12:37:07+00:00,@medpharm,13977,https://t.me/medpharm/13977,"–ë–æ–ª–µ–µ 9,6 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π –¥–æ–ø—Ñ–∏–Ω–∞–Ω—Å–∏—Ä–æ–≤–∞–Ω–∏—è –ø–æ–π–¥—É—Ç –Ω–∞ –æ–ø–ª–∞—Ç—É —Ç—Ä—É–¥–∞ –Ω–æ–≤—ã—Ö –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö —Ä–∞–±–æ—Ç–Ω–∏–∫–æ–≤ –≤ 2026 –≥–æ–¥—É. –†–∞–Ω–µ–µ —Å—Ç–∞–ª–æ –∏–∑–≤–µ—Å—Ç–Ω–æ –æ –∑–∞—Ç—Ä—É–¥–Ω–µ–Ω–∏—è—Ö —Ä–µ–≥–∏–æ–Ω–æ–≤ —Å –≤—ã–ø–æ–ª–Ω–µ–Ω–∏—è–º–∏ –ø—Ä–µ–∑–∏–¥–µ–Ω—Ç—Å–∫–∏—Ö —É–∫–∞–∑–æ–≤ –ø–æ –≤—ã–ø–ª–∞—Ç–∞–º –º–µ–¥—Ä–∞–±–æ—Ç–Ω–∏–∫–∞–º. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QnWGV #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{
  ""skip"": false,
  ""country"": ""regional"",
  ""topic"": ""demand, shortage"",
  ""impact"": ""high"",
  ""english"": ""More than 9.6 billion rubles of additional financing will be allocated for the payment of new medical staff salaries in 2026. It was previously known about difficulties for regions to fulfill the presidential orders on payments to healthcare workers.""
}"
2025-12-11T11:45:03+00:00,@medpharm,13976,https://t.me/medpharm/13976,–≠–∫—Å-–∑–∞–º–º–∏–Ω–∏—Å—Ç—Ä–∞ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –°—Ç–∞–≤—Ä–æ–ø–æ–ª—å—Å–∫–æ–≥–æ –∫—Ä–∞—è –ø—Ä–∏–∑–Ω–∞–ª–∏ –≤–∏–Ω–æ–≤–Ω–æ–π –≤ –ø—Ä–µ–≤—ã—à–µ–Ω–∏–∏ –ø–æ–ª–Ω–æ–º–æ—á–∏–π –∏–∑-–∑–∞ —Ñ–∏–∫—Ç–∏–≤–Ω–æ–≥–æ —Ç—Ä—É–¥–æ—É—Å—Ç—Ä–æ–π—Å—Ç–≤–∞ –∏ —É—Å–ª–æ–≤–Ω–æ –Ω–∞–∫–∞–∑–∞–ª–∏. –£–≤–æ–ª–∏–ª–∏ –ù–∞—Ç–∞–ª—å—é –ü–ª–æ—Ç–Ω–∏–∫–æ–≤—É –µ—â–µ –≤ –∏—é–Ω–µ. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QnSmb #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–î—Ä—É–≥–æ–µ,"{""skip"": true}"
2025-12-11T11:34:02+00:00,@medpharm,13975,https://t.me/medpharm/13975,"¬´–ö—Ä—É–≥ –¥–æ–±—Ä–∞¬ª –∑–∞–∫—É–ø–∏—Ç –æ–¥–∏–Ω –∏–∑ —Å–∞–º—ã—Ö –¥–æ—Ä–æ–≥–∏—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –æ—Ç –°–ú–ê –Ω–∞ 4,7 –º–ª—Ä–¥ —Ä—É–±. –§–æ–Ω–¥ –æ–±—ä—è–≤–∏–ª –∞—É–∫—Ü–∏–æ–Ω—ã –¥–ª—è –µ—â–µ –ø—è—Ç–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –¥–ª—è –¥–µ—Ç–µ–π —Å —Ä–µ–¥–∫–∏–º–∏ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è–º–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QnS3V #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–î–∏—Å—Ç—Ä–∏–±—É—Ü–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, shortage, demand"",
  ""impact"": ""high"",
  ""english"": ""The 'Circle of Good' will purchase one of the most expensive drugs for SMA at a cost of 4.7 billion rubles. The Fund has announced auctions for five other drugs for children with rare diseases. More details: <https://clck.ru/3QnS3V> #FarmaInvestor #Distribution""
}"
2025-12-11T10:48:06+00:00,@medpharm,13974,https://t.me/medpharm/13974,–í—Ä–∞—á–∏ –≤–æ—à–ª–∏ –≤ —Ä–µ–π—Ç–∏–Ω–≥ –≤—ã—Å–æ–∫–æ–æ–ø–ª–∞—á–∏–≤–∞–µ–º—ã—Ö —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–æ–≤ –≤ —Å–µ–º–∏ –≥–æ—Ä–æ–¥–∞—Ö-–º–∏–ª–ª–∏–æ–Ω–Ω–∏–∫–∞—Ö –†–æ—Å—Å–∏–∏ –≤ –¥–µ–∫–∞–±—Ä–µ 2025 –≥–æ–¥–∞. –°–∞–º—ã–º –¥–µ–Ω–µ–∂–Ω—ã–º —Å—Ç–∞–ª–æ –ø—Ä–µ–¥–ª–æ–∂–µ–Ω–∏–µ –¥–ª—è –∫–∞–Ω–¥–∏–¥–∞—Ç–∞ –Ω–∞ –¥–æ–ª–∂–Ω–æ—Å—Ç—å –≥–ª–∞–≤–≤—Ä–∞—á–∞ —á–∞—Å—Ç–Ω–æ–π –Ω–∞—Ä–∫–æ–ª–æ–≥–∏—á–µ—Å–∫–æ–π –∫–ª–∏–Ω–∏–∫–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QnNrC #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–î—Ä—É–≥–æ–µ,"{
  ""skip"": true
}"
2025-12-11T10:10:07+00:00,@medpharm,13973,https://t.me/medpharm/13973,¬´–î–æ—á–∫–∞¬ª Ipsen —É—Å—Ç—Ä–∞–Ω–∏–ª–∞ –Ω–∞—Ä—É—à–µ–Ω–∏—è –∞–Ω—Ç–∏–º–æ–Ω–æ–ø–æ–ª—å–Ω–æ–≥–æ –∑–∞–∫–æ–Ω–æ–¥–∞—Ç–µ–ª—å—Å—Ç–≤–∞ –ø–æ —Ç—Ä–µ–±–æ–≤–∞–Ω–∏—é –§–ê–°. –ö–æ–º–ø–∞–Ω–∏—è —É–±—Ä–∞–ª–∞ –∑–∞–≤—ã—à–µ–Ω–Ω—ã–µ —Ç—Ä–µ–±–æ–≤–∞–Ω–∏—è –∫ –¥–∏—Å—Ç—Ä–∏–±—å—é—Ç–æ—Ä–∞–º –∏ –ø–æ–≤—Ç–æ—Ä–Ω–æ —Ä–∞—Å—Å–º–æ—Ç—Ä–∏—Ç –∑–∞—è–≤–∫—É –∫–æ–º–ø–∞–Ω–∏–∏ ¬´–§–∞—Ä–º-–¢—Ä—ç–π–¥¬ª –ø–æ —Ç—Ä–µ–º –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞–º. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QnLCj #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–î–∏—Å—Ç—Ä–∏–±—É—Ü–∏—è,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""sanctions, regulation"",
  ""impact"": ""high"",
  ""english"": ""Ipsen's subsidiary resolved antitrust violations by the FAS. The company removed overpriced requirements for distributors and will reconsider a request from 'FarmaTrade' regarding three drugs. More details: https://clck.ru/3QnLCj #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–î–∏—Å—Ç—Ä–∏–±—É—Ü–∏—è""
}"
2025-12-11T09:46:02+00:00,@medpharm,13972,https://t.me/medpharm/13972,–ì—Ä—É–ø–ø–∞ –∫–æ–º–ø–∞–Ω–∏–π ¬´–†-–§–∞—Ä–º¬ª –∏ –ú–æ—Å–∫–æ–≤—Å–∫–∏–π –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã–π –æ–±—Ä–∞–∑–æ–≤–∞—Ç–µ–ª—å–Ω—ã–π –∫–æ–º–ø–ª–µ–∫—Å (–ú–ì–û–ö) –ø—Ä–∏ –ø–æ–¥–¥–µ—Ä–∂–∫–µ –ü–æ–ª–∏—Ç–µ—Ö–Ω–∏—á–µ—Å–∫–æ–≥–æ –∫–æ–ª–ª–µ–¥–∂–∞ (–ü–ö) –∏–º–µ–Ω–∏ –ü.–ê. –û–≤—á–∏–Ω–Ω–∏–∫–æ–≤–∞ –æ—Ç–∫—Ä—ã–ª–∏ —Ü–µ–Ω—Ç—Ä –ø–æ–¥–≥–æ—Ç–æ–≤–∫–∏ –∫–∞–¥—Ä–æ–≤ –ø–æ –∫–æ–º–ø–µ—Ç–µ–Ω—Ü–∏–∏ ¬´–ò–Ω–¥–∏–≤–∏–¥—É–∞–ª—å–Ω—ã–µ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∏–µ —Ä–µ—à–µ–Ω–∏—è¬ª. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QnJVq #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ö–∞—Ä—å–µ—Ä–∞,"{
  ""skip"": true
}"
2025-12-11T09:44:03+00:00,@medpharm,13971,https://t.me/medpharm/13971,"–ß–∞—Å—Ç—å —Ä–µ–≥–∏–æ–Ω–æ–≤ –º–æ–≥—É—Ç –∏—Å–ø—ã—Ç—ã–≤–∞—Ç—å —Å–ª–æ–∂–Ω–æ—Å—Ç–∏ —Å –≤—ã–ø–æ–ª–Ω–µ–Ω–∏–µ–º –ø–æ–∫–∞–∑–∞—Ç–µ–ª–µ–π –º–∞–π—Å–∫–∏—Ö —É–∫–∞–∑–æ–≤ –ü—Ä–µ–∑–∏–¥–µ–Ω—Ç–∞ –†–§ –ø–æ –∑–∞—Ä–ø–ª–∞—Ç–∞–º –º–µ–¥—Ä–∞–±–æ—Ç–Ω–∏–∫–æ–≤. –ù–æ –≤ –∫–æ–Ω—Ü–µ –≥–æ–¥–∞, –∫–∞–∫ –ø—Ä–∞–≤–∏–ª–æ, –Ω–µ–¥–æ—Å—Ç–∞—é—â–∏–µ —Å—Ä–µ–¥—Å—Ç–≤–∞ –¥–æ—Ñ–∏–Ω–∞–Ω—Å–∏—Ä—É—é—Ç—Å—è –∏–∑ –±—é–¥–∂–µ—Ç–∞ –§–µ–¥–µ—Ä–∞–ª—å–Ω–æ–≥–æ —Ñ–æ–Ω–¥–∞ –û–ú–°. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QnJNF #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""shortage, clinical_trial"",
  ""impact"": ""medium"",
  ""english"": ""Part of the regions may face difficulties in fulfilling the May President's instructions on salaries for healthcare workers. However, by the end of the year, usually missing funds are supplemented from the Federal Fund OMS budget. More details: https://clck.ru/3QnJNF #MedVestnik #Healthcare #WHO""
}"
2025-12-11T08:56:02+00:00,@medpharm,13970,https://t.me/medpharm/13970,–†–æ—Å—Å—Ç–∞—Ç –æ–ø—É–±–ª–∏–∫–æ–≤–∞–ª –¥–∞–Ω–Ω—ã–µ –æ —Ü–µ–Ω–∞—Ö –Ω–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –≤ –Ω–æ—è–±—Ä–µ. –í—Ç–æ—Ä–æ–π –º–µ—Å—è—Ü —Å–∏–ª—å–Ω–µ–µ –≤—Å–µ–≥–æ –¥–æ—Ä–æ–∂–∞–µ—Ç –±–µ—Ç–∞–ª–æ–∫ –ó–û–ö. –ö–∞–∫ –∏–∑–º–µ–Ω–∏–ª–∞—Å—å —Å—Ç–æ–∏–º–æ—Å—Ç—å –¥—Ä—É–≥–∏—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –∏ –º–µ–¥–∏–∑–¥–µ–ª–∏–π? –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QnF6g #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–æ–∑–Ω–∏—Ü–∞,"{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""pricing, clinical_trial"",
  ""impact"": ""medium"",
  ""english"": ""Rosstat published data on drug prices in November. Beta-Kol ZOK has experienced the second-largest increase in price after October. How have other medications and medical supplies changed? More details: https://clck.ru/3QnF6g #–§–∞—Ä–º–≤–µ—Å—Ç–∏–∫ #–†–æ–∑–Ω–∏—Ü–∞""
}"
2025-12-11T07:49:04+00:00,@medpharm,13969,https://t.me/medpharm/13969,"FDA —Ä–∞—Å—Å–ª–µ–¥—É–µ—Ç —Å–≤—è–∑—å –≤–∞–∫—Ü–∏–Ω –æ—Ç COVID-19 —Å–æ —Å–ª—É—á–∞—è–º–∏ —Å–º–µ—Ä—Ç–∏ —Å—Ä–µ–¥–∏ –¥–µ—Ç–µ–π –∏ —Ç–µ–ø–µ—Ä—å –≤–∑—Ä–æ—Å–ª—ã—Ö. –†–∞–Ω–µ–µ –≥–ª–∞–≤–∞ –≤–∞–∫—Ü–∏–Ω–Ω–æ–≥–æ –ø–æ–¥—Ä–∞–∑–¥–µ–ª–µ–Ω–∏—è —Ä–µ–≥—É–ª—è—Ç–æ—Ä–∞ —Å–¥–µ–ª–∞–ª –≥—Ä–æ–º–∫–æ–µ –∑–∞—è–≤–ª–µ–Ω–∏–µ –æ –ª–µ—Ç–∞–ª—å–Ω—ã—Ö –∏—Å—Ö–æ–¥–∞—Ö –ø–æ—Å–ª–µ –ø—Ä–æ—Ç–∏–≤–æ–∫–æ–≤–∏–¥–Ω—ã—Ö –ø—Ä–∏–≤–∏–≤–æ–∫, –Ω–æ –Ω–µ –ø—Ä–µ–¥–æ—Å—Ç–∞–≤–∏–ª –¥–æ–∫–∞–∑–∞—Ç–µ–ª—å—Å—Ç–≤. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QnAJg #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{""skip"": true}"
2025-12-11T06:04:06+00:00,@medpharm,13968,https://t.me/medpharm/13968,–ê–º–µ—Ä–∏–∫–∞–Ω—Å–∫–æ–µ –æ–Ω–∫–æ–ª–æ–≥–∏—á–µ—Å–∫–æ–µ –æ–±—â–µ—Å—Ç–≤–æ –ø—Ä–µ–¥—Å—Ç–∞–≤–∏–ª–æ –æ–±–Ω–æ–≤–ª–µ–Ω–Ω—ã–µ —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–∏ –ø–æ —Å–∫—Ä–∏–Ω–∏–Ω–≥—É —Ä–∞–∫–∞ —à–µ–π–∫–∏ –º–∞—Ç–∫–∏. –í –¥–æ–∫—É–º–µ–Ω—Ç –≤–∫–ª—é—á–µ–Ω—ã –ø–æ–ª–æ–∂–µ–Ω–∏—è –æ —Å–∞–º–æ—Å—Ç–æ—è—Ç–µ–ª—å–Ω–æ–º —Å–±–æ—Ä–µ –≤–∞–≥–∏–Ω–∞–ª—å–Ω—ã—Ö –æ–±—Ä–∞–∑—Ü–æ–≤ –¥–ª—è –í–ü–ß-—Ç–µ—Å—Ç–∏—Ä–æ–≤–∞–Ω–∏—è –∏ –ø–µ—Ä–µ—Å–º–æ—Ç—Ä–µ–Ω–Ω—ã–µ –∫—Ä–∏—Ç–µ—Ä–∏–∏ –ø—Ä–µ–∫—Ä–∞—â–µ–Ω–∏—è –æ–±—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Qn2jd #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–∞–∫—Ç–∏–∫–∞ #–ê–∫—É—à–µ—Ä—Å—Ç–≤–æ_–∏_–≥–∏–Ω–µ–∫–æ–ª–æ–≥–∏—è #–î–∏–∞–≥–Ω–æ—Å—Ç–∏–∫–∞ #–ò–Ω—Ñ–µ–∫—Ü–∏–æ–Ω–Ω—ã–µ_–±–æ–ª–µ–∑–Ω–∏ #–û–Ω–∫–æ–ª–æ–≥–∏—è,"{""skip"": true}"
2025-12-11T15:19:47+00:00,@gxpnews,7588,https://t.me/gxpnews/7588,"–¢–µ—Ö–Ω–æ–ª–æ–≥–∏—è CAR-T ‚Äî –æ–¥–∏–Ω –∏–∑ —Å–∞–º—ã—Ö –∏–Ω–Ω–æ–≤–∞—Ü–∏–æ–Ω–Ω—ã—Ö –ø–æ–¥—Ö–æ–¥–æ–≤ –≤ –æ–Ω–∫–æ–≥–µ–º–∞—Ç–æ–ª–æ–≥–∏–∏ ‚Äî –¥–∞–ª–∞ –Ω–∞–¥–µ–∂–¥—É –ø–∞—Ü–∏–µ–Ω—Ç–∞–º, –¥–ª—è –∫–æ—Ç–æ—Ä—ã—Ö —Å—Ç–∞–Ω–¥–∞—Ä—Ç–Ω—ã–µ –º–µ—Ç–æ–¥—ã –Ω–µ —Ä–∞–±–æ—Ç–∞—é—Ç. –ö–ª–µ—Ç–æ—á–Ω–∞—è —Ç–µ—Ä–∞–ø–∏—è –ø–æ–∫–∞–∑—ã–≤–∞–µ—Ç —Ä–µ–∑—É–ª—å—Ç–∞—Ç —Ç–∞–º, –≥–¥–µ –¥—Ä—É–≥–∏–µ —Å—Ç—Ä–∞—Ç–µ–≥–∏–∏ –ª–µ—á–µ–Ω–∏—è –ª–∏–º—Ñ–æ–º –∏ –ª–µ–π–∫–æ–∑–æ–≤ –±–µ—Å—Å–∏–ª—å–Ω—ã, –∑–∞ —á—Ç–æ –≤—Ä–∞—á–∏ –æ–∫—Ä–µ—Å—Ç–∏–ª–∏ –µ–µ ¬´—Ç–µ—Ä–∞–ø–∏–µ–π –æ—Ç—á–∞—è–Ω–∏—è¬ª. ‚û°Ô∏è –ú–æ–∂–Ω–æ –ª–∏ —Å—á–∏—Ç–∞—Ç—å CAR-T –ø–∞–Ω–∞—Ü–µ–µ–π –∏ —Å—Ç–∞–Ω–µ—Ç –ª–∏ –æ–Ω–∞ —á–∞—Å—Ç—å—é —Ä—É—Ç–∏–Ω–Ω–æ–π –∫–ª–∏–Ω–∏—á–µ—Å–∫–æ–π –ø—Ä–∞–∫—Ç–∏–∫–∏ ‚Äî –≤—ã—è—Å–Ω—è–ª–∞ —Ä–µ–¥–∞–∫—Ü–∏—è GxP News.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, demand, epidemic"",
  ""impact"": ""high"",
  ""english"": ""CAR-T cell therapy is described as a promising approach in oncology and hematological diseases by GxP News. It has shown success where other treatment methods have failed for lymphoma and leukemia patients. The article discusses whether CAR-T will become a routine clinical practice.""
}"
2025-12-11T14:19:01+00:00,@gxpnews,7587,https://t.me/gxpnews/7587,[–ú–∞—Ä–∫–µ—Ç–∏–Ω–≥] –£ –∫–æ–º–ø–∞–Ω–∏–∏ ¬´–û–∑–æ–Ω –§–∞—Ä–º–∞—Ü–µ–≤—Ç–∏–∫–∞¬ª –ø–æ—è–≤–∏–ª—Å—è —Å–æ–±—Å—Ç–≤–µ–Ω–Ω—ã–π –º–∞—Å–∫–æ—Ç.,"{""skip"": true}"
2025-12-11T13:42:38+00:00,@gxpnews,7586,https://t.me/gxpnews/7586,[–ò–Ω–∏—Ü–∏–∞—Ç–∏–≤–∞] –í –ì–æ—Å–¥—É–º–µ –ø—Ä–µ–¥–ª–æ–∂–∏–ª–∏ –ø—Ä–æ–¥–∞–≤–∞—Ç—å —ç–Ω–µ—Ä–≥–µ—Ç–∏–∫–∏ –∏—Å–∫–ª—é—á–∏—Ç–µ–ª—å–Ω–æ –≤ –∞–ø—Ç–µ–∫–∞—Ö. –ö–∞–∫ –≤–∞–º –∏–¥–µ—è? üíä ‚Äî –µ—Å–ª–∏ –∑–∞ üò± ‚Äî –µ—Å–ª–∏ –ø—Ä–æ—Ç–∏–≤,"{
  ""skip"": true
}"
2025-12-11T10:40:35+00:00,@gxpnews,7585,https://t.me/gxpnews/7585,"[–†–µ–≥—É–ª–∏—Ä–æ–≤–∞–Ω–∏–µ] –†–æ—Å—Å–∏–π—Å–∫–∞—è ¬´–¥–æ—á–∫–∞¬ª Ipsen –ø–µ—Ä–µ—Å–º–æ—Ç—Ä–µ–ª–∞ —Ç—Ä–µ–±–æ–≤–∞–Ω–∏—è –∫ –¥–∏—Å—Ç—Ä–∏–±—É—Ç–æ—Ä–∞–º –ø–æ —Ç—Ä–µ–±–æ–≤–∞–Ω–∏—é —Ä–µ–≥—É–ª—è—Ç–æ—Ä–∞. –ø–æ–∑–≤–æ–ª—è–µ—Ç —É–≤–µ–ª–∏—á–∏—Ç—å –∫–æ–ª–∏—á–µ—Å—Ç–≤–æ –¥–∏—Å—Ç—Ä–∏–±—É—Ç–æ—Ä–æ–≤, –∫–æ—Ç–æ—Ä—ã–µ –±—É–¥—É—Ç –∫–æ–Ω–∫—É—Ä–∏—Ä–æ–≤–∞—Ç—å –º–µ–∂–¥—É —Å–æ–±–æ–π, –ø—Ä–µ–¥–ª–∞–≥–∞—è –≥–æ—Å–∑–∞–∫–∞–∑—á–∏–∫–∞–º, –∞–ø—Ç–µ–∫–∞–º –∏, —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤–µ–Ω–Ω–æ, –≥—Ä–∞–∂–¥–∞–Ω–∞–º –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –ø–æ –±–æ–ª–µ–µ –Ω–∏–∑–∫–∏–º —Ü–µ–Ω–∞–º, ‚Äî –ø—Ä–µ—Å—Å-—Å–ª—É–∂–±–∞ –§–ê–° –†–æ—Å—Å–∏–∏","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""reimbursement, regulation"",
  ""impact"": ""high"",
  ""english"": ""The Russian branch of Ipsen has revised distributor requirements at the regulator's request. This allows for an increase in the number of distributors competing with each other, offering medicines to government buyers, pharmacies, and ultimately citizens at lower prices, according to FAS Russia press release.""
}"
2025-12-11T09:52:42+00:00,@gxpnews,7584,https://t.me/gxpnews/7584,"‚ö°Ô∏è–†–æ—Å—Å–∏—è –∏ –û–ê–≠ –ø–æ–¥–ø–∏—Å–∞–ª–∏ –º–µ–º–æ—Ä–∞–Ω–¥—É–º –æ –ø—Ä–∏–∑–Ω–∞–Ω–∏–∏ GMP-–ø—Ä–∞–∫—Ç–∏–∫. –≠—Ç–æ –∫—Ä–∞–π–Ω–µ –≤–∞–∂–Ω—ã–π –ø–µ—Ä–≤—ã–π —à–∞–≥, —á—Ç–æ–±—ã –ø—Ä–∏–π—Ç–∏ –∫ –≤–∑–∞–∏–º–Ω–æ–º—É –ø—Ä–∏–∑–Ω–∞–Ω–∏—é GMP-–ª–∏—Ü–µ–Ω–∑–∏–∏, –∫–æ—Ç–æ—Ä—ã–µ –≤—ã–¥–∞—é—Ç—Å—è –≤ –≠–º–∏—Ä–∞—Ç–∞—Ö –∏ –†–æ—Å—Å–∏–∏. –≠—Ç–æ –¥–æ–ª–∂–Ω–æ —Å—É—â–µ—Å—Ç–≤–µ–Ω–Ω–æ –æ–±–ª–µ–≥—á–∏—Ç—å –≤—ã—Ö–æ–¥ —Ä–æ—Å—Å–∏–π—Å–∫–∏—Ö —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∏—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –Ω–∞ —Ä—ã–Ω–æ–∫ –≠–º–∏—Ä–∞—Ç–æ–≤, ‚Äî –ê–Ω—Ç–æ–Ω –ê–ª–∏—Ö–∞–Ω–æ–≤, –≥–ª–∞–≤–∞ –ú–∏–Ω–ø—Ä–æ–º—Ç–æ—Ä–≥–∞ –†–§","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""regulation, registration"",
  ""impact"": ""high"",
  ""english"": ""Russia and the UAE have signed a memorandum on mutual recognition of GMP practices. This is a crucial first step towards mutual recognition of GMP licenses issued in the Emirates and Russia. It should significantly ease the export of Russian pharmaceutical products to the Emirates market, according to Anton Alikhanov, Minister of Industry and Trade of Russia.""
}"
2025-12-11T07:57:47+00:00,@gxpnews,7583,https://t.me/gxpnews/7583,–í –°–®–ê –æ–¥–æ–±—Ä–∏–ª–∏ –ø–µ—Ä–≤—É—é –∫–ª–µ—Ç–æ—á–Ω—É—é —Ç–µ—Ä–∞–ø–∏—é –¥–ª—è –ª–µ—á–µ–Ω–∏—è –∞–ø–ª–∞—Å—Ç–∏—á–µ—Å–∫–æ–π –∞–Ω–µ–º–∏–∏.,"{""skip"": true}"
2025-12-11T06:02:01+00:00,@gxpnews,7582,https://t.me/gxpnews/7582,[–ü—Ä–æ–≥–Ω–æ–∑] –ö–æ–Ω—Å–æ–ª–∏–¥–∞—Ü–∏—è –∞–ø—Ç–µ—á–Ω–æ–≥–æ —Ä—ã–Ω–∫–∞ –ø—Ä–∏–≤–µ–¥–µ—Ç –∫ —Ä–æ—Å—Ç—É —Ü–µ–Ω –Ω–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞.,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""demand, pricing"",
  ""impact"": ""high"",
  ""english"": ""The forecast predicts an increase in drug prices due to consolidation of the pharmacy market.""
}"
2025-12-11T04:02:01+00:00,@gxpnews,7581,https://t.me/gxpnews/7581,"[–ë–∏–≥—Ñ–∞—Ä–º–∞] Eli Lilly –æ–ø—Ä–µ–¥–µ–ª–∏–ª–∞—Å—å —Å –º–µ—Å—Ç–æ–ø–æ–ª–æ–∂–µ–Ω–∏–µ–º —Ç—Ä–µ—Ç—å–µ–≥–æ –∏–∑ —á–µ—Ç—ã—Ä–µ—Ö –∑–∞–≤–æ–¥–æ–≤, –∫–æ—Ç–æ—Ä—ã–µ –ø–ª–∞–Ω–∏—Ä—É–µ—Ç –ø–æ—Å—Ç—Ä–æ–∏—Ç—å –≤ –°–®–ê. –í –ø—Ä–µ–¥–ø—Ä–∏—è—Ç–∏–µ –ø–æ –≤—ã–ø—É—Å–∫—É —Ñ–∞—Ä–º—Å—É–±—Å—Ç–∞–Ω—Ü–∏–π –¥–ª—è –ø–µ–ø—Ç–∏–¥–Ω—ã—Ö –∏ –Ω–∏–∑–∫–æ–º–æ–ª–µ–∫—É–ª—è—Ä–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –∫–æ–º–ø–∞–Ω–∏—è –≤–ª–æ–∂–∏—Ç $6 –º–ª—Ä–¥.","{""skip"": true}"
2025-12-11T01:55:01+00:00,@gxpnews,7580,https://t.me/gxpnews/7580,[–†–µ–≥—É–ª–∏—Ä–æ–≤–∞–Ω–∏–µ] –ú–∏–Ω–∑–¥—Ä–∞–≤ –¥–æ–±–∞–≤–∏–ª –≤ –ø–æ–∫–∞–∑–∞–Ω–∏—è –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ ¬´–ê—Ä–µ–π–º–∞¬ª (–∫–∞–º—Ä–µ–ª–∏–∑—É–º–∞–±) –ª–µ—á–µ–Ω–∏–µ –Ω–µ–º–µ–ª–∫–æ–∫–ª–µ—Ç–æ—á–Ω–æ–≥–æ —Ä–∞–∫–∞ –ª–µ–≥–∫–æ–≥–æ.,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration"",
  ""impact"": ""high"",
  ""english"": ""The Ministry of Health added the treatment of non-small cell lung cancer to the indications for the drug 'Aryema' (camrelizumab). This is a significant regulatory change impacting global pharmaceutical filings and market access.""
}"
2025-12-11T15:45:00+00:00,@pharmvestnik,8371,https://t.me/pharmvestnik/8371,"–í —Ç–µ–∫—É—â–µ–º –≥–æ–¥—É –º–Ω–æ–≥–∏–µ –∫–æ–º–ø–∞–Ω–∏–∏ —É–≤–µ–ª–∏—á–∏–ª–∏ –≤–æ–∑–Ω–∞–≥—Ä–∞–∂–¥–µ–Ω–∏–µ, –≤—ã–ø–ª–∞—á–∏–≤–∞–µ–º–æ–µ –≤ —Ä–∞–º–∫–∞—Ö —Ä–µ—Ñ–µ—Ä–∞–ª—å–Ω—ã—Ö –ø—Ä–æ–≥—Ä–∞–º–º. –ó–∞ –ø—Ä–∏–≤–µ–¥–µ–Ω–Ω–æ–≥–æ –Ω–∞ –≤–∞–∫–∞–Ω—Å–∏—é –¥—Ä—É–≥–∞ —Å–æ—Ç—Ä—É–¥–Ω–∏–∫ —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–∏ –º–æ–∂–µ—Ç –ø–æ–ª—É—á–∏—Ç—å –¥–æ 80 —Ç—ã—Å. —Ä—É–±. –ö–∞–∫ —Ä–∞–±–æ—Ç–∞—é—Ç –ø—Ä–æ–≥—Ä–∞–º–º—ã, –≤—ã—è—Å–Ω–∏–ª ¬´–§–í¬ª. #–≠–∫—Å–∫–ª—é–∑–∏–≤ #–ö–∞—Ä—å–µ—Ä–∞","{""skip"": true}"
2025-12-11T13:54:15+00:00,@pharmvestnik,8369,https://t.me/pharmvestnik/8369,–í –†–æ—Å—Å–∏–∏ –ø–æ—è–≤–∏—Ç—Å—è —Ä–µ–µ—Å—Ç—Ä –æ —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤–∏–∏ —Ñ–∞—Ä–º–≤—É–∑–æ–≤ —Ç—Ä–µ–±–æ–≤–∞–Ω–∏—è–º –ø—Ä–∞–∫—Ç–∏—á–µ—Å–∫–æ–π –ø–æ–¥–≥–æ—Ç–æ–≤–∫–∏ —Å—Ç—É–¥–µ–Ω—Ç–æ–≤. –ö–∞–∫ –†–æ—Å–∑–¥—Ä–∞–≤–Ω–∞–¥–∑–æ—Ä –±—É–¥–µ—Ç –≤–µ—Å—Ç–∏ —Ä–µ–µ—Å—Ç—Ä? #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞,"{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""registration, clinical_trial"",
  ""impact"": ""high"",
  ""english"": ""The Russian Health Supervision Agency will be managing a registry of pharmaceutical universities that meet the practical training requirements for students. How will the registration process work?""
}"
2025-12-11T13:00:49+00:00,@pharmvestnik,8368,https://t.me/pharmvestnik/8368,"–ò–ò –∏—Å–ø–æ–ª—å–∑—É–µ—Ç—Å—è –¥–ª—è —Å–æ–∑–¥–∞–Ω–∏—è –∫–∞–∂–¥–æ–≥–æ —Ç—Ä–µ—Ç—å–µ–≥–æ –Ω–æ–≤–æ–≥–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞, –∞ –∑–∞–Ω–∏–º–∞—é—â–∏–µ—Å—è —ç—Ç–∏–º –µ–≤—Ä–æ–ø–µ–π—Å–∫–∏–µ —Å—Ç–∞—Ä—Ç–∞–ø—ã –ø—Ä–∏–≤–ª–µ–∫–ª–∏ –±–æ–ª–µ–µ 2 –º–ª—Ä–¥ –¥–æ–ª–ª. –∑–∞ 2025 –≥–æ–¥. –û–¥–Ω–∞–∫–æ –∏–Ω–≤–µ—Å—Ç–∏—Ü–∏–∏ —Ä–∞—Å–ø—Ä–µ–¥–µ–ª—è—é—Ç—Å—è –Ω–µ—Ä–∞–≤–Ω–æ–º–µ—Ä–Ω–æ. #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{""skip"": true}"
2025-12-11T11:44:26+00:00,@pharmvestnik,8367,https://t.me/pharmvestnik/8367,"¬´–ö—Ä—É–≥ –¥–æ–±—Ä–∞¬ª –∑–∞–∫—É–ø–∏—Ç –æ–¥–∏–Ω –∏–∑ —Å–∞–º—ã—Ö –¥–æ—Ä–æ–≥–∏—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –æ—Ç –°–ú–ê –Ω–∞ 4,7 –º–ª—Ä–¥ —Ä—É–±. –§–æ–Ω–¥ –æ–±—ä—è–≤–∏–ª –∞—É–∫—Ü–∏–æ–Ω—ã –¥–ª—è –µ—â–µ –ø—è—Ç–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –¥–ª—è –¥–µ—Ç–µ–π —Å —Ä–µ–¥–∫–∏–º–∏ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è–º–∏. #–î–∏—Å—Ç—Ä–∏–±—É—Ü–∏—è","{
  ""skip"": false,
  ""country"": ""regional"",
  ""topic"": ""tenders, shortage, demand"",
  ""impact"": ""high"",
  ""english"": ""The 'Circle of Good' will purchase one of the most expensive drugs for SMA at a cost of 4.7 billion rubles. The Fund has announced auctions for five other drugs for children with rare diseases.""
}"
2025-12-11T08:56:43+00:00,@pharmvestnik,8365,https://t.me/pharmvestnik/8365,–†–æ—Å—Å—Ç–∞—Ç –æ–ø—É–±–ª–∏–∫–æ–≤–∞–ª –¥–∞–Ω–Ω—ã–µ –æ —Ü–µ–Ω–∞—Ö –Ω–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –≤ –Ω–æ—è–±—Ä–µ. –í—Ç–æ—Ä–æ–π –º–µ—Å—è—Ü —Å–∏–ª—å–Ω–µ–µ –≤—Å–µ–≥–æ –¥–æ—Ä–æ–∂–∞–µ—Ç –±–µ—Ç–∞–ª–æ–∫ –ó–û–ö. –ö–∞–∫ –∏–∑–º–µ–Ω–∏–ª–∞—Å—å —Å—Ç–æ–∏–º–æ—Å—Ç—å –¥—Ä—É–≥–∏—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –∏ –º–µ–¥–∏–∑–¥–µ–ª–∏–π? #–†–æ–∑–Ω–∏—Ü–∞,"{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""pricing, shortage"",
  ""impact"": ""medium"",
  ""english"": ""Rosstat published data on drug prices in November. Beta-Kok ZOK has experienced the second-largest price increase after October. How have the prices of other medications and medical supplies changed?""
}"
2025-12-11T12:56:29+00:00,@pharmnewskz,6595,https://t.me/pharmnewskz/6595,"–ú–∏–Ω–∏—Å—Ç–µ—Ä—Å–∫–∏–π –∫—Ä–æ—Å—Å—Ñ–∏—Ç: –∫–∞–¥—Ä–æ–≤—ã–π –≤—ã–≤–æ–¥, –∫–æ—Ç–æ—Ä—ã–π –ø–µ—Ä–µ—á–µ—Ä–∫–∏–≤–∞–µ—Ç –≤—Å–µ –Ω–æ—Ä–º–∞—Ç–∏–≤—ã –í —Å–µ—Ç–∏ –≤–∑–æ—Ä–≤–∞–ª–∞—Å—å –∏—Å—Ç–æ—Ä–∏—è –æ —Ç–æ–º, –∫–∞–∫ –≤ –∞—ç—Ä–æ–ø–æ—Ä—Ç—É –∏–º–µ–Ω–∏ –†–µ–π–≥–∞–Ω–∞ —É—Å—Ç—Ä–æ–∏–ª–∏ –∏–º–ø—Ä–æ–≤–∏–∑–∏—Ä–æ–≤–∞–Ω–Ω—É—é –ø—Ä–æ–≤–µ—Ä–∫—É –Ω–µ –±–∞–≥–∞–∂–∞, –∞ —Å–∏–ª—ã –≤–æ–ª–∏ –∏ –º—ã—à—Ü. –†–µ–∑—É–ª—å—Ç–∞—Ç—ã, –µ—Å–ª–∏ –≤–µ—Ä–∏—Ç—å –∏—Å—Ç–æ—á–Ω–∏–∫—É, –æ—Ç–º–µ–Ω—è—é—Ç –≤—Å–µ –Ω–∞—à–∏ –ø—Ä–µ–¥—Å—Ç–∞–≤–ª–µ–Ω–∏—è –æ –≤–æ–∑—Ä–∞—Å—Ç–µ, –∫–∞—Ä—å–µ—Ä–µ –∏ –ø—Ä–∏–æ—Ä–∏—Ç–µ—Ç–∞—Ö. –ü—Ä–æ—Ç–æ–∫–æ–ª —Å–æ—Ä–µ–≤–Ω–æ–≤–∞–Ω–∏–π —É –ø–µ—Ä–µ–∫–ª–∞–¥–∏–Ω—ã: ‚Ä¢ 71 –≥–æ–¥ (–ì–ª–∞–≤–∞ –ú–∏–Ω–∑–¥—Ä–∞–≤–∞): 20 –ø–æ–¥—Ç—è–≥–∏–≤–∞–Ω–∏–π. –§–∞–∫—Ç–∏—á–µ—Å–∫–∏ –æ—Ç–º–µ–Ω–∏–ª –ø–µ–Ω—Å–∏–æ–Ω–Ω—ã–π –≤–æ–∑—Ä–∞—Å—Ç –æ–¥–Ω–∏–º –ø–æ–¥—Ö–æ–¥–æ–º. –ï–≥–æ –≤–µ–¥–æ–º—Å—Ç–≤—É —Ç–µ–ø–µ—Ä—å, –≤–æ–∑–º–æ–∂–Ω–æ, –ø—Ä–∏–¥–µ—Ç—Å—è –ø–µ—Ä–µ–ø–∏—Å—ã–≤–∞—Ç—å –Ω–æ—Ä–º–∞—Ç–∏–≤—ã –ø–æ –≥–µ—Ä–æ–Ω—Ç–æ–ª–æ–≥–∏–∏ –∏ –ó–û–ñ. ‚Ä¢ 54 –≥–æ–¥–∞ (–ì–ª–∞–≤–∞ –ú–∏–Ω—Ç—Ä–∞–Ω—Å–∞): 10 –ø–æ–≤—Ç–æ—Ä–æ–≤. –í –ª—É—á—à–∏–µ –≥–æ–¥—ã –ø–æ–∫–∞–∑–∞–ª —Ä–µ–∑—É–ª—å—Ç–∞—Ç –≤–ø–æ–ª–æ–≤–∏–Ω—É —Ö—É–∂–µ —Å–µ–º–∏–¥–µ—Å—è—Ç–∏–ª–µ—Ç–Ω–µ–≥–æ –∫–æ–ª–ª–µ–≥–∏. –Ø–≤–Ω—ã–π –ø–µ—Ä–µ–∫–æ—Å –≤ —Å—Ç–æ—Ä–æ–Ω—É –ª–æ–≥–∏—Å—Ç–∏–∫–∏, –∞ –Ω–µ –ª–∏—á–Ω–æ–π —Ñ–∏–∑–ø–æ–¥–≥–æ—Ç–æ–≤–∫–∏. ‚Ä¢ 48 –ª–µ—Ç (–ò–∑–≤–µ—Å—Ç–Ω—ã–π –±–ª–æ–≥–µ—Ä-–Ω—É—Ç—Ä–∏—Ü–∏–æ–ª–æ–≥): 21 –ø–æ–≤—Ç–æ—Ä. –ú–ª–∞–¥—à–µ –º–∏–Ω–∏—Å—Ç—Ä–∞ —Ç—Ä–∞–Ω—Å–ø–æ—Ä—Ç–∞, –Ω–æ –æ–±–æ–≥–Ω–∞–ª –≤—Å–µ—Ö. –•–æ—Ç—è, —É—á–∏—Ç—ã–≤–∞—è —Å–æ—Å—Ç–∞–≤ —Å–æ–ø–µ—Ä–Ω–∏–∫–æ–≤, —Ç–∞–∫–∞—è –ø–æ–±–µ–¥–∞ –±–æ–ª—å—à–µ –ø–æ—Ö–æ–∂–∞ –Ω–∞ —Ç–∞–∫—Ç–∏—á–µ—Å–∫–æ–µ –ø–æ—Ä–∞–∂–µ–Ω–∏–µ ‚Äî –∂–¥–∞–ª –±–æ–ª–µ–µ —Å–µ—Ä—å—ë–∑–Ω–æ–π –∫–æ–Ω–∫—É—Ä–µ–Ω—Ü–∏–∏. –í—ã–≤–æ–¥ –Ω–∞–ø—Ä–∞—à–∏–≤–∞–µ—Ç—Å—è —Å–∞–º —Å–æ–±–æ–π - –æ—Ñ–∏—Ü–∏–∞–ª—å–Ω—ã–π –≤–æ–∑—Ä–∞—Å—Ç –∏ –¥–æ–ª–∂–Ω–æ—Å—Ç—å –±–æ–ª–µ–µ –Ω–µ —è–≤–ª—è—é—Ç—Å—è –æ–±—ä–µ–∫—Ç–∏–≤–Ω—ã–º–∏ –ø–æ–∫–∞–∑–∞—Ç–µ–ª—è–º–∏ —Ñ–æ—Ä–º—ã. –ò—Å—Ç–æ—Ä–∏—è, –∫–æ–Ω–µ—á–Ω–æ, –∏–∑ —Ä–∞–∑—Ä—è–¥–∞ ¬´—Å–ª–∏—à–∫–æ–º —Ö–æ—Ä–æ—à–æ, —á—Ç–æ–±—ã –±—ã—Ç—å –ø—Ä–∞–≤–¥–æ–π¬ª, –Ω–æ –º–æ—Ç–∏–≤–∞—Ü–∏–æ–Ω–Ω–∞—è ‚Äî –æ—Ç–ª–∏—á–Ω–∞—è. –ò–Ω—Ç–µ—Ä–µ—Å–Ω–æ, —á—Ç–æ –±—É–¥–µ—Ç, –µ—Å–ª–∏ –ø–æ—Å—Ç–∞–≤–∏—Ç—å —Ç–∞–∫—É—é –ø–µ—Ä–µ–∫–ª–∞–¥–∏–Ω—É –≤ –Ω–∞—à–µ–º –∞—ç—Ä–æ–ø–æ—Ä—Ç—É?","{""skip"": true}"
2025-12-11T12:55:32+00:00,@pharmnewskz,6594,https://t.me/pharmnewskz/6594,"–í –ø–æ–≥–æ–Ω–µ –∑–∞ –∑–¥–æ—Ä–æ–≤—å–µ–º –∏ –ø—Ä–æ–∫–∞—á–∞–Ω–Ω—ã–º —Ç–µ–ª–æ–º –Ω–µ –≤—Å–µ–≥–¥–∞ —Ç—Ä—É–¥—è–≥–∏ —Å–ø–æ—Ä—Ç–∑–∞–ª–∞ –º–æ–≥—É—Ç —Å–ø—Ä–∞–≤–∏—Ç—å—Å—è —Å –æ–±—ã—á–Ω—ã–º, –∫–∞–∑–∞–ª–æ—Å—å –±—ã, —ç–ª–µ–º–µ–Ω—Ç–æ–º ‚Äî –ø—Ä–∞–≤–∏–ª—å–Ω—ã–º —Ö–≤–∞—Ç–æ–º —à—Ç–∞–Ω–≥–∏. –ò–≥–Ω–æ—Ä–∏—Ä–æ–≤–∞–Ω–∏–µ —ç—Ç–æ–≥–æ –ø—Ä–∞–≤–∏–ª–∞ –º–æ–∂–µ—Ç –æ–±–µ—Ä–Ω—É—Ç—å—Å—è —Ç—Ä–∞–≥–µ–¥–∏–µ–π. –ú—É–∂—á–∏–Ω–∞ –≤–æ –≤—Ä–µ–º—è –∂–∏–º–∞ –ª–µ–∂–∞ –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–ª —Ç–∞–∫ –Ω–∞–∑—ã–≤–∞–µ–º—ã–π ¬´–æ—Ç–∫—Ä—ã—Ç—ã–π¬ª –∏–ª–∏ ¬´—Å–∞–º–æ—É–±–∏–π—Å—Ç–≤–µ–Ω–Ω—ã–π¬ª —Ö–≤–∞—Ç (–±–µ–∑ –±–æ–ª—å—à–æ–≥–æ –ø–∞–ª—å—Ü–∞). –ì—Ä–∏—Ñ –≤—ã—Å–∫–æ–ª—å–∑–Ω—É–ª –∏ —Å —Å–∏–ª–æ–π —É–¥–∞—Ä–∏–ª –µ–≥–æ –≤ –≥—Ä—É–¥—å, –≤—ã–∑–≤–∞–≤ –æ—Å—Ç–∞–Ω–æ–≤–∫—É —Å–µ—Ä–¥—Ü–∞. –¢–∞–∫–æ–π —Ö–≤–∞—Ç –¥–µ–π—Å—Ç–≤–∏—Ç–µ–ª—å–Ω–æ –Ω–∞ –∫–æ—Ä–æ—Ç–∫–∏–π –º–∏–≥ –º–æ–∂–µ—Ç –∫–∞–∑–∞—Ç—å—Å—è ¬´—É–¥–æ–±–Ω–µ–µ¬ª, –Ω–æ –æ–Ω –ª–∏—à–∞–µ—Ç –≤–∞—Å –≥–ª–∞–≤–Ω–æ–≥–æ ‚Äî –∫–æ–Ω—Ç—Ä–æ–ª—è. –®—Ç–∞–Ω–≥–∞ –ª–µ–∂–∏—Ç –≤ –ª–∞–¥–æ–Ω–∏, –∞ –Ω–µ –∑–∞–∂–∞—Ç–∞ –≤ ¬´–∑–∞–º–æ–∫¬ª. –î–æ—Å—Ç–∞—Ç–æ—á–Ω–æ –º–∞–ª–µ–π—à–µ–≥–æ —Å–º–µ—â–µ–Ω–∏—è, —É—Å—Ç–∞–ª–æ—Å—Ç–∏ –∏–ª–∏ –ø–æ—Ç–∞ –Ω–∞ –ª–∞–¥–æ–Ω—è—Ö ‚Äî –∏ –≤—ã —É–∂–µ –Ω–µ —É–¥–µ—Ä–∂–∏—Ç–µ –≤–µ—Å, –∫–æ—Ç–æ—Ä—ã–π –æ–±—Ä—É—à–∏—Ç—Å—è –Ω–∞ –≤–∞—à–µ —Ç–µ–ª–æ. –ñ–µ–ª–µ–∑–Ω–æ–µ –ø—Ä–∞–≤–∏–ª–æ, –∫–æ—Ç–æ—Ä–æ–µ —Å–ø–∞—Å–∞–µ—Ç –∂–∏–∑–Ω–∏: ¬´–í—Å–µ–≥–¥–∞ –æ–±—Ö–≤–∞—Ç—ã–≤–∞–π—Ç–µ –≥—Ä–∏—Ñ –±–æ–ª—å—à–∏–º –ø–∞–ª—å—Ü–µ–º, —Å–æ–∑–¥–∞–≤–∞—è –ø–æ–ª–Ω—ã–π –∑–∞–º–æ–∫ –≤–æ–∫—Ä—É–≥ –Ω–µ–≥–æ¬ª. –≠—Ç–æ —Ñ—É–Ω–¥–∞–º–µ–Ω—Ç–∞–ª—å–Ω–æ –∏ –Ω–µ –æ–±—Å—É–∂–¥–∞–µ—Ç—Å—è. –ë–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç—å ‚Äî —ç—Ç–æ –Ω–µ —Å–∫—É—á–Ω–æ. –≠—Ç–æ –æ–±—è–∑–∞—Ç–µ–ª—å–Ω–æ.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""safety"",
  ""impact"": ""high"",
  ""english"": ""A man using an improper grip during a barbell lie-down exercise, called the 'open' or 'suicide' grip without his thumb, had the bar slip and hit him in the chest, causing cardiac arrest. This grip can seem convenient for a short moment but it takes away control. The rule is to always use the full grip around the bar with your thumb, which saves lives. Safety is fundamental and not boring.""
}"
2025-12-11T12:54:23+00:00,@pharmnewskz,6593,https://t.me/pharmnewskz/6593,"–î–æ–Ω–æ—Ä —Å–ø–µ—Ä–º—ã —Å –æ–ø–∞—Å–Ω–æ–π –º—É—Ç–∞—Ü–∏–µ–π —Å—Ç–∞–ª –±–∏–æ–ª–æ–≥–∏—á–µ—Å–∫–∏–º –æ—Ç—Ü–æ–º –ø–æ—á—Ç–∏ 200 –¥–µ—Ç–µ–π –≤ –ï–≤—Ä–æ–ø–µ –£ –¥–æ–Ω–æ—Ä–∞ —Å–ø–µ—Ä–º—ã –∏–∑ –î–∞–Ω–∏–∏ –≤—ã—è–≤–∏–ª–∏ —Ä–µ–¥–∫—É—é –º—É—Ç–∞—Ü–∏—é –≤ –≥–µ–Ω–µ TP53 ‚Äî –∫–ª—é—á–µ–≤–æ–º –≥–µ–Ω–µ-—Å—É–ø—Ä–µ—Å—Å–æ—Ä–µ –æ–ø—É—Ö–æ–ª–µ–π, –∫–æ—Ç–æ—Ä—ã–π –æ—Ç–≤–µ—á–∞–µ—Ç –∑–∞ –ø—Ä–µ–¥–æ—Ç–≤—Ä–∞—â–µ–Ω–∏–µ –ø–µ—Ä–µ—Ä–æ–∂–¥–µ–Ω–∏—è –Ω–æ—Ä–º–∞–ª—å–Ω—ã—Ö –∫–ª–µ—Ç–æ–∫ –≤ —Ä–∞–∫–æ–≤—ã–µ. –ù–µ—Å–º–æ—Ç—Ä—è –Ω–∞ —ç—Ç–æ—Ç –¥–µ—Ñ–µ–∫—Ç, –º—É–∂—á–∏–Ω–∞ —É—Å–ø–µ–ª —Å—Ç–∞—Ç—å –æ—Ç—Ü–æ–º –∫–∞–∫ –º–∏–Ω–∏–º—É–º 197 –¥–µ—Ç–µ–π –≤ —Ä–∞–∑–Ω—ã—Ö —Å—Ç—Ä–∞–Ω–∞—Ö –ï–≤—Ä–æ–ø—ã. –ú—É—Ç–∞—Ü–∏—è –±—ã–ª–∞ –æ–±–Ω–∞—Ä—É–∂–µ–Ω–∞ –ø—Ä–∏–º–µ—Ä–Ω–æ –≤ 20% —Å–ø–µ—Ä–º–∞—Ç–æ–∑–æ–∏–¥–æ–≤. –ß–∞—Å—Ç—å –¥–µ—Ç–µ–π, —É–Ω–∞—Å–ª–µ–¥–æ–≤–∞–≤—à–∏—Ö –µ—ë, –≤–ø–æ—Å–ª–µ–¥—Å—Ç–≤–∏–∏ —É–º–µ—Ä–ª–∏ –æ—Ç –æ–Ω–∫–æ–ª–æ–≥–∏—á–µ—Å–∫–∏—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π. –î–æ–Ω–æ—Ä –Ω–∞—á–∞–ª —Å–æ—Ç—Ä—É–¥–Ω–∏—á–µ—Å—Ç–≤–æ —Å –ï–≤—Ä–æ–ø–µ–π—Å–∫–∏–º –±–∞–Ω–∫–æ–º —Å–ø–µ—Ä–º—ã (ESB) –≤ 2005 –≥–æ–¥—É, –∏ –µ–≥–æ –±–∏–æ–º–∞—Ç–µ—Ä–∏–∞–ª –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–ª—Å—è –≤ 67 –∫–ª–∏–Ω–∏–∫–∞—Ö –≤ 14 —Å—Ç—Ä–∞–Ω–∞—Ö. –î–µ—Ç–∏ –æ—Ç —ç—Ç–æ–≥–æ –¥–æ–Ω–æ—Ä–∞ —Ä–æ–¥–∏–ª–∏—Å—å –≤ –î–∞–Ω–∏–∏, –ë–µ–ª—å–≥–∏–∏, –ò—Å–ø–∞–Ω–∏–∏, –ì–µ—Ä–º–∞–Ω–∏–∏, –ò—Å–ª–∞–Ω–¥–∏–∏. –°–ø–µ—Ä–º–∞ –ø–æ—Å—Ç–∞–≤–ª—è–ª–∞—Å—å —Ç–∞–∫–∂–µ –≤ –ü–æ–ª—å—à—É, –ê–ª–±–∞–Ω–∏—é, –ò—Ä–ª–∞–Ω–¥–∏—é, –°–µ—Ä–±–∏—é –∏ –ö–æ—Å–æ–≤–æ, –Ω–æ —Ç–∞–º –±–µ—Ä–µ–º–µ–Ω–Ω–æ—Å—Ç–µ–π –Ω–µ –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–Ω–æ. –ù–∞ –º–æ–º–µ–Ω—Ç –Ω–∞—á–∞–ª–∞ –¥–æ–Ω–æ—Ä—Å—Ç–≤–∞ –º—É–∂—á–∏–Ω–∞ –ø—Ä–æ—à—ë–ª –≤—Å–µ —Å—Ç–∞–Ω–¥–∞—Ä—Ç–Ω—ã–µ –æ–±—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è –∏ –±—ã–ª –ø—Ä–∏–∑–Ω–∞–Ω –ø–æ–ª–Ω–æ—Å—Ç—å—é –∑–¥–æ—Ä–æ–≤—ã–º. –ú—É—Ç–∞—Ü–∏—é –≤ –±–∏–æ–º–∞—Ç–µ—Ä–∏–∞–ª–µ –≤—ã—è–≤–∏–ª–∏ —Ç–æ–ª—å–∫–æ –≤ 2023 –≥–æ–¥—É, –ø–æ—Å–ª–µ —á–µ–≥–æ –µ–≥–æ –¥–æ–Ω–æ—Ä—Å–∫–∏–π –ø—Ä–æ—Ñ–∏–ª—å –Ω–µ–º–µ–¥–ª–µ–Ω–Ω–æ –∑–∞–±–ª–æ–∫–∏—Ä–æ–≤–∞–ª–∏. –í ESB –ø–æ—è—Å–Ω–∏–ª–∏, —á—Ç–æ —Ç–∞–∫–∞—è —Ä–∞–∑–Ω–æ–≤–∏–¥–Ω–æ—Å—Ç—å –º—É—Ç–∞—Ü–∏–∏ –Ω–µ –æ–ø—Ä–µ–¥–µ–ª—è–µ—Ç—Å—è –ø—Ä–∏ —Ä—É—Ç–∏–Ω–Ω–æ–º –≥–µ–Ω–µ—Ç–∏—á–µ—Å–∫–æ–º —Å–∫—Ä–∏–Ω–∏–Ω–≥–µ, –∞ —Å–∞–º –¥–æ–Ω–æ—Ä –∏ –µ–≥–æ —Ä–æ–¥—Å—Ç–≤–µ–Ω–Ω–∏–∫–∏ –Ω–µ –±–æ–ª–µ—é—Ç –æ–Ω–∫–æ–ª–æ–≥–∏—á–µ—Å–∫–∏–º–∏ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è–º–∏. –≠—Ç–æ—Ç —Å–ª—É—á–∞–π –∞–∫—Ç–∏–≤–Ω–æ –æ–±—Å—É–∂–¥–∞–µ—Ç—Å—è —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–∞–º–∏ –∫–∞–∫ –ø—Ä–∏–º–µ—Ä —Ç–æ–≥–æ, —á—Ç–æ —Å—É—â–µ—Å—Ç–≤—É—é—â–∏–µ –ø—Ä–æ—Ç–æ–∫–æ–ª—ã —Å–∫—Ä–∏–Ω–∏–Ω–≥–∞ –¥–æ–Ω–æ—Ä–æ–≤ –º–æ–≥—É—Ç –∏–º–µ—Ç—å –ø—Ä–æ–±–µ–ª—ã ‚Äî –æ—Å–æ–±–µ–Ω–Ω–æ –≤ —á–∞—Å—Ç–∏ —Ä–µ–¥–∫–∏—Ö –≥–µ–Ω–µ—Ç–∏—á–µ—Å–∫–∏—Ö –º—É—Ç–∞—Ü–∏–π, –Ω–µ –ø—Ä–æ—è–≤–ª—è—é—â–∏—Ö—Å—è —É —Å–∞–º–æ–≥–æ –Ω–æ—Å–∏—Ç–µ–ª—è.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, safety, clinical_trial"",
  ""impact"": ""high"",
  ""english"": ""A Danish sperm donor with a rare mutation in the TP53 gene (a key tumor suppressor gene) has fathered at least 197 children across Europe. The mutation was found in approximately 20% of his sperm samples. Some of these children later died from cancer. Despite being healthy, the donor's profile was immediately blocked after a rare genetic mutation was identified in 2023. This case highlights potential gaps in existing screening protocols for donors and raises concerns about unreported genetic mutations.""
}"
2025-12-11T12:50:08+00:00,@pharmnewskz,6592,https://t.me/pharmnewskz/6592,"FDA –∑–∞–ø—É—Å–∫–∞–µ—Ç –ø–∏–ª–æ—Ç–Ω—ã–π –ø—Ä–æ–µ–∫—Ç —Å –Ω–æ—Å–∏–º—ã–º–∏ —É—Å—Ç—Ä–æ–π—Å—Ç–≤–∞–º–∏ –¥–ª—è –ª–µ—á–µ–Ω–∏—è —Ö—Ä–æ–Ω–∏—á–µ—Å–∫–∏—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π ‚Äî –Ω–æ –¥–µ–π—Å—Ç–≤–∏—Ç–µ–ª—å–Ω–æ –ª–∏ —ç—Ç–æ ¬´–ø–µ—Ä–≤—ã–π¬ª –≤ –º–∏—Ä–µ? FDA –æ–±—ä—è–≤–∏–ª–æ –æ —Å—Ç–∞—Ä—Ç–µ —Å–≤–æ–µ–≥–æ ¬´–ø–µ—Ä–≤–æ–≥–æ¬ª –ø–∏–ª–æ—Ç–Ω–æ–≥–æ –ø—Ä–æ–µ–∫—Ç–∞, –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω–Ω–æ–≥–æ –Ω–∞ –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏–µ —Ü–∏—Ñ—Ä–æ–≤—ã—Ö –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–π –¥–ª—è —É–ª—É—á—à–µ–Ω–∏—è –∏—Å—Ö–æ–¥–æ–≤ –ø—Ä–∏ —Ö—Ä–æ–Ω–∏—á–µ—Å–∫–∏—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è—Ö. –¶–µ–ª—å –∏–Ω–∏—Ü–∏–∞—Ç–∏–≤—ã ‚Äî —É—Å–∫–æ—Ä–∏—Ç—å –¥–æ—Å—Ç—É–ø –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –∫ –ø—Ä–æ–≤–µ—Ä–µ–Ω–Ω—ã–º –Ω–æ—Å–∏–º—ã–º —É—Å—Ç—Ä–æ–π—Å—Ç–≤–∞–º, –Ω–µ —Å–Ω–∏–∂–∞—è –ø—Ä–∏ —ç—Ç–æ–º —Å—Ç–∞–Ω–¥–∞—Ä—Ç–æ–≤ –±–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç–∏. –° —è–Ω–≤–∞—Ä—è 2026 –≥–æ–¥–∞ —Ä–∞–∑—Ä–∞–±–æ—Ç—á–∏–∫–∏ —Å–º–æ–≥—É—Ç –ø–æ–¥–∞–≤–∞—Ç—å –∑–∞—è–≤–∫–∏ –Ω–∞ —É—á–∞—Å—Ç–∏–µ –≤ –ø—Ä–æ–≥—Ä–∞–º–º–µ. –í –Ω–µ–π –ø—Ä–∏–º—É—Ç —É—á–∞—Å—Ç–∏–µ —É—Å—Ç—Ä–æ–π—Å—Ç–≤–∞, –ø—Ä–µ–¥–Ω–∞–∑–Ω–∞—á–µ–Ω–Ω—ã–µ –¥–ª—è –ª–µ—á–µ–Ω–∏—è –∏ –º–æ–Ω–∏—Ç–æ—Ä–∏–Ω–≥–∞ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π —Å–µ—Ä–¥–µ—á–Ω–æ-—Å–æ—Å—É–¥–∏—Å—Ç–æ–π, –ø–æ—á–µ—á–Ω–æ–π, –º–µ—Ç–∞–±–æ–ª–∏—á–µ—Å–∫–æ–π, –æ–ø–æ—Ä–Ω–æ-–¥–≤–∏–≥–∞—Ç–µ–ª—å–Ω–æ–π —Å–∏—Å—Ç–µ–º, –∞ —Ç–∞–∫–∂–µ —Ä–∞—Å—Å—Ç—Ä–æ–π—Å—Ç–≤ –ø–æ–≤–µ–¥–µ–Ω—á–µ—Å–∫–æ–≥–æ —Ö–∞—Ä–∞–∫—Ç–µ—Ä–∞. –£—á–∞—Å—Ç–Ω–∏–∫–∞–º –ø—Ä–æ–µ–∫—Ç–∞ –æ–±–µ—â–∞—é—Ç –∑–Ω–∞—á–∏—Ç–µ–ª—å–Ω—ã–µ –ø—Ä–µ—Ñ–µ—Ä–µ–Ω—Ü–∏–∏: —É–ø—Ä–æ—â—ë–Ω–Ω—É—é —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏—é –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –∏–∑–¥–µ–ª–∏–π, –≥–∏–±–∫–æ—Å—Ç—å –≤ —Ä–µ–≥—É–ª—è—Ç–æ—Ä–Ω—ã—Ö —Ç—Ä–µ–±–æ–≤–∞–Ω–∏—è—Ö –∏ –¥–∞–∂–µ –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç—å –≤–æ–∑–º–µ—â–µ–Ω–∏—è –∑–∞—Ç—Ä–∞—Ç —á–µ—Ä–µ–∑ —Å—Ç—Ä–∞—Ö–æ–≤—ã–µ –∫–æ–º–ø–∞–Ω–∏–∏ ‚Äî —à–∞–≥, –∫–æ—Ç–æ—Ä—ã–π –º–æ–∂–µ—Ç —Å—Ç–∞—Ç—å –º–æ—â–Ω—ã–º —Å—Ç–∏–º—É–ª–æ–º –¥–ª—è –≤–Ω–µ–¥—Ä–µ–Ω–∏—è —Ü–∏—Ñ—Ä–æ–≤—ã—Ö —Ä–µ—à–µ–Ω–∏–π –≤ —Ä–µ–∞–ª—å–Ω—É—é –∫–ª–∏–Ω–∏—á–µ—Å–∫—É—é –ø—Ä–∞–∫—Ç–∏–∫—É. –û–¥–Ω–∞–∫–æ —Å—Ç–æ–∏—Ç –æ—Ç–º–µ—Ç–∏—Ç—å: –Ω–∞–∑–≤–∞—Ç—å —ç—Ç—É –∏–Ω–∏—Ü–∏–∞—Ç–∏–≤—É ¬´–ø–µ—Ä–≤–æ–π –≤ –º–∏—Ä–µ¬ª ‚Äî —Å–∏–ª—å–Ω–æ–µ –ø—Ä–µ—É–≤–µ–ª–∏—á–µ–Ω–∏–µ. –ù–∞–ø—Ä–∏–º–µ—Ä, –≤ –†–æ—Å—Å–∏–∏ —Å 2023 –≥–æ–¥–∞ —Ä–µ–∞–ª–∏–∑—É–µ—Ç—Å—è –ø—Ä–æ–µ–∫—Ç –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ ¬´–ü–µ—Ä—Å–æ–Ω–∞–ª—å–Ω—ã–µ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–µ –ø–æ–º–æ—â–Ω–∏–∫–∏¬ª, –≤ —Ä–∞–º–∫–∞—Ö –∫–æ—Ç–æ—Ä–æ–≥–æ —É–∂–µ –∏—Å–ø–æ–ª—å–∑—É—é—Ç—Å—è –Ω–æ—Å–∏–º—ã–µ —É—Å—Ç—Ä–æ–π—Å—Ç–≤–∞ –¥–ª—è –¥–∏—Å—Ç–∞–Ω—Ü–∏–æ–Ω–Ω–æ–≥–æ –Ω–∞–±–ª—é–¥–µ–Ω–∏—è –∑–∞ –ø–∞—Ü–∏–µ–Ω—Ç–∞–º–∏. –° –Ω–∞—á–∞–ª–∞ 2025 –≥–æ–¥–∞ –≤ –ø—Ä–æ–≥—Ä–∞–º–º—É –≤–∫–ª—é—á–∏–ª–∏ –¥–∞–∂–µ –±–µ—Ä–µ–º–µ–Ω–Ω—ã—Ö ‚Äî –¥–ª—è –º–æ–Ω–∏—Ç–æ—Ä–∏–Ω–≥–∞ —Å–µ—Ä–¥—Ü–µ–±–∏–µ–Ω–∏—è –ø–ª–æ–¥–∞ —Å –ø–æ–º–æ—â—å—é —Ü–∏—Ñ—Ä–æ–≤—ã—Ö —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–π. –¢–∞–∫–∏–º –æ–±—Ä–∞–∑–æ–º, –°–®–ê, —Å–∫–æ—Ä–µ–µ, –ø—Ä–∏—Å–æ–µ–¥–∏–Ω—è—é—Ç—Å—è –∫ –≥–ª–æ–±–∞–ª—å–Ω–æ–º—É —Ç—Ä–µ–Ω–¥—É –Ω–∞ –∏–Ω—Ç–µ–≥—Ä–∞—Ü–∏—é –Ω–æ—Å–∏–º–æ–π —ç–ª–µ–∫—Ç—Ä–æ–Ω–∏–∫–∏ –≤ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ, –∞ –Ω–µ –∑–∞–¥–∞—é—Ç –µ–≥–æ. https://www.fda.gov/news-events/press-announcements/fda-launches-tempo-first-its-kind-digital-health-pilot-expand-access-chronic-disease-technologies","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, reimbursement, clinical_trial"",
  ""impact"": ""high"",
  ""english"": ""The FDA announced the launch of its first pilot project aimed at using digital medical technologies to improve outcomes for chronic diseases. The goal is to expedite patients' access to verified wearable devices without compromising safety standards. Starting in January 2026, developers can submit applications to participate in the program. Devices intended for treating and monitoring cardiovascular, renal, metabolic, musculoskeletal system disorders, as well as behavioral health conditions will be included. Participants are promised significant benefits: simplified medical device registration, flexible regulatory requirements, and even reimbursement of costs through insurance companies ‚Äì a move that could serve as a powerful incentive to integrate digital solutions into real clinical practice. However, it should be noted: calling this initiative 'first in the world' is an overstatement. For example, since 2023, Russia has implemented the Ministry of Health's 'Personal Medical Assistants' project, where wearable devices are already used for remote patient monitoring. Since January 2025, even pregnant women have been included ‚Äì to monitor fetal heart rate using digital technologies. Thus, the US"
2025-12-11T12:48:23+00:00,@pharmnewskz,6591,https://t.me/pharmnewskz/6591,"11 –¥–µ–∫–∞–±—Ä—è ‚Äî –í—Å–µ–º–∏—Ä–Ω—ã–π –¥–µ–Ω—å –±–æ–ª—å–Ω–æ–≥–æ –±—Ä–æ–Ω—Ö–∏–∞–ª—å–Ω–æ–π –∞—Å—Ç–º–æ–π –ë—Ä–æ–Ω—Ö–∏–∞–ª—å–Ω–∞—è –∞—Å—Ç–º–∞ ‚Äî —Ö—Ä–æ–Ω–∏—á–µ—Å–∫–æ–µ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–µ –¥—ã—Ö–∞—Ç–µ–ª—å–Ω–æ–π —Å–∏—Å—Ç–µ–º—ã, –ø—Ä–∏ –∫–æ—Ç–æ—Ä–æ–º –ø–µ—Ä–∏–æ–¥–∏—á–µ—Å–∫–∏ –≤–æ–∑–Ω–∏–∫–∞—é—Ç –æ–¥—ã—à–∫–∞, —É–¥—É—à—å–µ, –∑–∞—Ç—Ä—É–¥–Ω—ë–Ω–Ω–æ–µ –¥—ã—Ö–∞–Ω–∏–µ, –ø—Ä–∏—Å—Ç—É–ø—ã –∫–∞—à–ª—è –∏–ª–∏ —Å–≤–∏—Å—Ç—è—â–µ–µ –¥—ã—Ö–∞–Ω–∏–µ ‚Äî –∏–Ω–æ–≥–¥–∞ —Å–ª—ã—à–∏–º–æ–µ –Ω–∞ —Ä–∞—Å—Å—Ç–æ—è–Ω–∏–∏. –ó–∞ –ø–æ—Å–ª–µ–¥–Ω–∏–µ –¥–µ—Å—è—Ç–∏–ª–µ—Ç–∏—è –∞—Å—Ç–º–∞ –ø–µ—Ä–µ—Å—Ç–∞–ª–∞ –±—ã—Ç—å —Ä–µ–¥–∫–∏–º –¥–∏–∞–≥–Ω–æ–∑–æ–º. –í –†–æ—Å—Å–∏–∏, –Ω–∞–ø—Ä–∏–º–µ—Ä, –±–æ–ª–µ–∑–Ω—å –∑–∞—Ç—Ä–∞–≥–∏–≤–∞–µ—Ç –º–∏–ª–ª–∏–æ–Ω—ã –ª—é–¥–µ–π. –ß–∞—Å—Ç–æ –∞—Å—Ç–º–æ–π –±–æ–ª–µ—é—Ç –¥–µ—Ç–∏: –ø—Ä–∏–º–µ—Ä–Ω–æ –≤ –ø–æ–ª–æ–≤–∏–Ω–µ —Å–ª—É—á–∞–µ–≤ –ø–µ—Ä–≤—ã–µ —Å–∏–º–ø—Ç–æ–º—ã –ø–æ—è–≤–ª—è—é—Ç—Å—è –≤ –≤–æ–∑—Ä–∞—Å—Ç–µ 5‚Äì10 –ª–µ—Ç. –í –ö–∞–∑–∞—Ö—Å—Ç–∞–Ω–µ –∞—Å—Ç–º–∞ —Ç–∞–∫–∂–µ –æ—Å—Ç–∞—ë—Ç—Å—è —Å—É—â–µ—Å—Ç–≤–µ–Ω–Ω–æ–π –ø—Ä–æ–±–ª–µ–º–æ–π –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è. –ü–æ –¥–∞–Ω–Ω—ã–º –∫—Ä—É–ø–Ω–æ–≥–æ –º–Ω–æ–≥–æ—Ü–µ–Ω—Ç—Ä–æ–≤–æ–≥–æ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è (CORE study), –∫–æ—Ç–æ—Ä–æ–µ –æ—Ö–≤–∞—Ç–∏–ª–æ –≤–∑—Ä–æ—Å–ª–æ–µ –Ω–∞—Å–µ–ª–µ–Ω–∏–µ —Ç—Ä—ë—Ö —Å—Ç—Ä–∞–Ω ‚Äî –≤–∫–ª—é—á–∞—è –ö–∞–∑–∞—Ö—Å—Ç–∞–Ω ‚Äî –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–Ω–Ω—ã–π —É—Ä–æ–≤–µ–Ω—å ¬´–∞—Å—Ç–º—ã, –ø–æ–¥—Ç–≤–µ—Ä–∂–¥—ë–Ω–Ω–æ–π –≤—Ä–∞—á–æ–º¬ª –≤ —Ä–µ—Å–ø—É–±–ª–∏–∫–µ —Å–æ—Å—Ç–∞–≤–∏–ª –æ–∫–æ–ª–æ 19 –Ω–∞ 1000 —á–µ–ª–æ–≤–µ–∫. –î—Ä—É–≥–∏–µ –∏—Å—Ç–æ—á–Ω–∏–∫–∏ –æ—Ç–º–µ—á–∞—é—Ç, —á—Ç–æ —Å—Ä–µ–¥–∏ –¥–µ—Ç–µ–π —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏—è –±—Ä–æ–Ω—Ö–∏–∞–ª—å–Ω–æ–π –∞—Å—Ç–º—ã –≤ –ö–∞–∑–∞—Ö—Å—Ç–∞–Ω–µ –≤–∞—Ä—å–∏—Ä—É–µ—Ç—Å—è –æ—Ç 2.5 % –¥–æ 5 %. –≠—Ç–∏ –¥–∞–Ω–Ω—ã–µ —É–∫–∞–∑—ã–≤–∞—é—Ç –Ω–∞ –Ω–µ–æ–±—Ö–æ–¥–∏–º–æ—Å—Ç—å –ø–æ–≤—ã—à–µ–Ω–Ω–æ–≥–æ –≤–Ω–∏–º–∞–Ω–∏—è –∫ –¥–∏–∞–≥–Ω–æ—Å—Ç–∏–∫–µ, –∫–æ–Ω—Ç—Ä–æ–ª—é –∏ –ª–µ—á–µ–Ω–∏—é –∞—Å—Ç–º—ã ‚Äî –æ—Å–æ–±–µ–Ω–Ω–æ —Å—Ä–µ–¥–∏ –¥–µ—Ç–µ–π –∏ —É—è–∑–≤–∏–º—ã—Ö –≥—Ä—É–ø–ø –Ω–∞—Å–µ–ª–µ–Ω–∏—è.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""demand,safety,vaccine"",
  ""impact"": ""high"",
  ""english"": ""Bronchial asthma is a chronic respiratory disease characterized by periodic episodes of shortness of breath, choking, difficulty breathing, coughing or wheezing sounds. In recent decades, asthma has become less rare. In Russia, for example, the disease affects millions of people. Asthma often affects children: about half of cases first appear in children aged 5-10 years. Asthma is also a significant health problem in Kazakhstan. According to a large multicenter study (CORE study) that included adult populations from three countries including Kazakhstan, the registered level 'asthma confirmed by a doctor' in the republic was approximately 19 per 1000 people. Other sources note that among children, asthma registration in Kazakhstan varies from 2.5% to 5%. These data indicate the need for increased attention to diagnosis, control and treatment of asthma ‚Äî especially among children and vulnerable groups.""
}"
2025-12-11T06:03:06+00:00,@pharmnewskz,6590,https://t.me/pharmnewskz/6590,"–°—Ä–∞–∑—É –Ω–µ—Å–∫–æ–ª—å–∫–æ –¥–µ–ø—É—Ç–∞—Ç—Å–∫–∏—Ö –∑–∞–ø—Ä–æ—Å–æ–≤, –æ–∑–≤—É—á–µ–Ω–Ω—ã—Ö –≤ –ú–∞–∂–∏–ª–∏—Å–µ, —É–∫–∞–∑—ã–≤–∞—é—Ç –Ω–∞ —Å–∏—Å—Ç–µ–º–Ω—ã–µ —Å–±–æ–∏ –≤ —Å—Ñ–µ—Ä–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –æ–±–µ—Å–ø–µ—á–µ–Ω–∏—è –ö–∞–∑–∞—Ö—Å—Ç–∞–Ω–∞ ‚Äî –æ—Ç —Ñ–∏–∫—Ç–∏–≤–Ω–æ–π –ª–æ–∫–∞–ª–∏–∑–∞—Ü–∏–∏ –∏ —É–≥—Ä–æ–∑—ã –º–æ–Ω–æ–ø–æ–ª–∏–∑–∞—Ü–∏–∏ –¥–æ –æ—à–∏–±–æ–∫ –≤ –Ω–∞–ª–æ–≥–æ–≤–æ–π –ø–æ–ª–∏—Ç–∏–∫–µ, —É—Å–∏–ª–∏–≤–∞—é—â–∏—Ö —Ä–æ—Å—Ç —Ü–µ–Ω. –î–µ–ø—É—Ç–∞—Ç –ú–∞–∂–∏–ª–∏—Å–∞ –ö–æ–Ω—Å—Ç–∞–Ω—Ç–∏–Ω –ê–≤–µ—Ä—à–∏–Ω –∑–∞—è–≤–∏–ª –æ –º–∞—Å—Å–æ–≤–æ–π –∏–º–∏—Ç–∞—Ü–∏–∏ –ª–æ–∫–∞–ª–∏–∑–∞—Ü–∏–∏ –ø—Ä–∏ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–µ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –∏–∑–¥–µ–ª–∏–π. –ü–æ –µ–≥–æ —Å–ª–æ–≤–∞–º, –Ω–∞ —Ä—ã–Ω–æ–∫ –≥–æ—Å–∑–∞–∫—É–ø–æ–∫ –ø–æ–¥ –≤–∏–¥–æ–º –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø–æ—Å—Ç—É–ø–∞—é—Ç —Ñ–∞–∫—Ç–∏—á–µ—Å–∫–∏ –≥–æ—Ç–æ–≤—ã–µ –∏–º–ø–æ—Ä—Ç–Ω—ã–µ –∏–∑–¥–µ–ª–∏—è, –∫–æ—Ç–æ—Ä—ã–µ –ª–∏—à—å —É–ø–∞–∫–æ–≤—ã–≤–∞—é—Ç—Å—è –≤ –ö–∞–∑–∞—Ö—Å—Ç–∞–Ω–µ. –î–µ–ø—É—Ç–∞—Ç –û–°–î–ü –ù—É—Ä–ª–∞–Ω –ê—É–µ—Å–±–∞–µ–≤ —Ä–∞—Å–∫—Ä–∏—Ç–∏–∫–æ–≤–∞–ª –≤–≤–µ–¥—ë–Ω–Ω—ã–π –≤ –ø–∏–ª–æ—Ç–Ω–æ–º —Ä–µ–∂–∏–º–µ –º–µ—Ö–∞–Ω–∏–∑–º —Å–æ—Ñ–∏–Ω–∞–Ω—Å–∏—Ä–æ–≤–∞–Ω–∏—è –ª–µ–∫–∞—Ä—Å—Ç–≤, –∫–æ–≥–¥–∞ –ø–∞—Ü–∏–µ–Ω—Ç—ã –º–æ–≥—É—Ç –ø–æ–ª—É—á–∏—Ç—å –ø—Ä–µ–ø–∞—Ä–∞—Ç –±–µ—Å–ø–ª–∞—Ç–Ω–æ –∏–ª–∏ –≤—ã–±—Ä–∞—Ç—å –±–æ–ª–µ–µ –¥–æ—Ä–æ–≥–æ–π –≤–∞—Ä–∏–∞–Ω—Ç —Å –¥–æ–ø–ª–∞—Ç–æ–π. –¢—Ä–µ—Ç–∏–π –¥–µ–ø—É—Ç–∞—Ç—Å–∫–∏–π –∑–∞–ø—Ä–æ—Å ‚Äî –æ—Ç –ë–µ—Ä–∏–∫–∞ –ë–µ–π—Å–µ–Ω–≥–∞–ª–∏–µ–≤–∞ (—Ñ—Ä–∞–∫—Ü–∏—è ¬´AMANAT¬ª) ‚Äî –∫–∞—Å–∞–µ—Ç—Å—è –Ω–∞–ª–æ–≥–æ–≤–æ–π –ø–æ–ª–∏—Ç–∏–∫–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ –Ω–∞: https://pharmnewskz.com/ru/news/deputaty-trebuyut-peresmotra-lekarstvennoy-politiki-fiktivnoe-proizvodstvo-spornaya-sooplata-i-riski-udorozhaniya-preparatov_25858","{
  ""skip"": false,
  ""country"": ""Kazakhstan"",
  ""topic"": ""regulation, reimbursement, pricing, shortage"",
  ""impact"": ""high"",
  ""english"": ""Several parliamentary inquiries in the Kazakhstani Majilis have highlighted systemic failures in the pharmaceutical sector. Issues include fake localization and threats of monopolization, as well as errors in tax policy that are contributing to rising prices. Konstantin Avershin, a Majilis deputy, criticized the mass imitation of domestic production for medical devices, where imported products are merely repackaged in Kazakhstan. Nurlan Auesbaev, another deputy from OSDP, criticized the pilot financing mechanism for medications, which allows patients to receive free drugs or choose more expensive options with additional payments. The third inquiry by Berik Bayesenbayeva (AMANAT faction) concerns tax policy.""  
}"
2025-12-11T06:02:19+00:00,@pharmnewskz,6589,https://t.me/pharmnewskz/6589,"–ê–ª–º–∞—Ç–∏–Ω—Å–∫–∏–π –æ–Ω–∫–æ–ª–æ–≥–∏—á–µ—Å–∫–∏–π —Ü–µ–Ω—Ç—Ä –ø—Ä–æ–≤–æ–¥–∏—Ç –î–µ–Ω—å –æ—Ç–∫—Ä—ã—Ç—ã—Ö –¥–≤–µ—Ä–µ–π, –ø–æ—Å–≤—è—â—ë–Ω–Ω—ã–π –ø–æ–≤—ã—à–µ–Ω–∏—é –æ—Å–≤–µ–¥–æ–º–ª—ë–Ω–Ω–æ—Å—Ç–∏ –æ —Ä–∞–∫–µ –∂–µ–ª—É–¥–∫–∞, –ø–æ–¥–∂–µ–ª—É–¥–æ—á–Ω–æ–π –∂–µ–ª–µ–∑—ã –∏ –ø–µ—á–µ–Ω–∏. –ú–µ—Ä–æ–ø—Ä–∏—è—Ç–∏–µ —Å–æ—Å—Ç–æ–∏—Ç—Å—è 13 –¥–µ–∫–∞–±—Ä—è 2025 –≥–æ–¥–∞ —Å 09:00 –¥–æ 13:00 —Å —É—á–∞—Å—Ç–∏–µ–º –≤—Ä–∞—á–µ–π-–æ–Ω–∫–æ–ª–æ–≥–æ–≤. –í —Ä–∞–º–∫–∞—Ö –º–µ—Ä–æ–ø—Ä–∏—è—Ç–∏—è –±—É–¥–µ—Ç –ø—Ä–µ–¥–æ—Å—Ç–∞–≤–ª–µ–Ω–∞ –±–µ—Å–ø–ª–∞—Ç–Ω–∞—è –∫–æ–Ω—Å—É–ª—å—Ç–∞—Ü–∏—è —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–æ–≤, –∞ —Ç–∞–∫–∂–µ –£–ó–ò –æ—Ä–≥–∞–Ω–æ–≤ –±—Ä—é—à–Ω–æ–π –ø–æ–ª–æ—Å—Ç–∏ –ø–æ –ø–æ–∫–∞–∑–∞–Ω–∏—è–º. –ú–µ—Å—Ç–æ –ø—Ä–æ–≤–µ–¥–µ–Ω–∏—è: –ê–ª–º–∞—Ç–∏–Ω—Å–∫–∏–π –æ–Ω–∫–æ–ª–æ–≥–∏—á–µ—Å–∫–∏–π —Ü–µ–Ω—Ç—Ä, –≥. –ê–ª–º–∞—Ç—ã, —É–ª. –ü–∞–ø–∞–Ω–∏–Ω–∞, 220, –ª–∏—Ç–µ—Ä –ê, 1-–π —ç—Ç–∞–∂. –ü—Ä–æ–µ–∑–¥: –∞–≤—Ç–æ–±—É—Å—ã ‚Ññ 27, 74, 85, 86, 92, 114, 121. –û—Å—Ç–∞–Ω–æ–≤–∫–∞: ¬´‚Ññ 4 –≥–æ—Ä–æ–¥—Å–∫–∞—è –±–æ–ª—å–Ω–∏—Ü–∞¬ª. –î–æ–ø–æ–ª–Ω–∏—Ç–µ–ª—å–Ω–∞—è –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏—è –ø–æ —Ç–µ–ª–µ—Ñ–æ–Ω—É: +7 (727) 312-24-74.","{
  ""skip"": true
}"
2025-12-11T06:01:02+00:00,@pharmnewskz,6587,https://t.me/pharmnewskz/6587,"–ù–∞ –≤–Ω–µ–æ—á–µ—Ä–µ–¥–Ω–æ–π —Å–µ—Å—Å–∏–∏ –º–∞—Å–ª–∏—Ö–∞—Ç–∞ –ê–ª–º–∞—Ç—ã –ø–æ–¥–¥–µ—Ä–∂–∞–Ω–æ —Ä–µ—à–µ–Ω–∏–µ –æ —Ä–∞—Å—à–∏—Ä–µ–Ω–∏–∏ –ø–µ—Ä–µ—á–Ω—è –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π –∏ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö —Å—Ä–µ–¥—Å—Ç–≤ –¥–ª—è –∂–∏—Ç–µ–ª–µ–π –º–µ–≥–∞–ø–æ–ª–∏—Å–∞, –∂–∏–≤—É—â–∏—Ö —Å –æ—Ä—Ñ–∞–Ω–Ω—ã–º–∏ –ø–∞—Ç–æ–ª–æ–≥–∏—è–º–∏. –ü–æ–≤–æ–¥–æ–º –¥–ª—è —Ä–∞—Å—Å–º–æ—Ç—Ä–µ–Ω–∏—è –≤–æ–ø—Ä–æ—Å–∞ —Å—Ç–∞–ª —Ä–µ–∑–∫–∏–π —Ä–æ—Å—Ç —Ç–∞–∫–∏—Ö —Å–ª—É—á–∞–µ–≤ –≤ –ø–æ—Å–ª–µ–¥–Ω–∏–µ –≥–æ–¥—ã. –í—Ä–µ–º–µ–Ω–Ω–æ –∏—Å–ø–æ–ª–Ω—è—é—â–∞—è –æ–±—è–∑–∞–Ω–Ω–æ—Å—Ç–∏ —Ä—É–∫–æ–≤–æ–¥–∏—Ç–µ–ª—è –£–ø—Ä–∞–≤–ª–µ–Ω–∏—è –æ–±—â–µ—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –ê–ª–º–∞—Ç—ã –õ–∞–π–ª–∞ –ò–º–∞–Ω–≥–∞–ª–∏–µ–≤–∞ –ø–æ–¥—á—ë—Ä–∫–∏–≤–∞–µ—Ç, —á—Ç–æ –¥–∏–Ω–∞–º–∏–∫–∞ –±–µ—Å–ø—Ä–µ—Ü–µ–¥–µ–Ω—Ç–Ω–∞: ¬´–ï—Å–ª–∏ –≤ 2017 –≥–æ–¥—É —É –Ω–∞—Å –±—ã–ª–æ –≤—Å–µ–≥–æ 140 –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å —Ä–µ–¥–∫–∏–º–∏ –¥–∏–∞–≥–Ω–æ–∑–∞–º–∏, —Ç–æ —Å–µ–≥–æ–¥–Ω—è ‚Äì —É–∂–µ 4 287¬ª. –ò–º–µ–Ω–Ω–æ –ø–æ—ç—Ç–æ–º—É —Ä–∞—Å—à–∏—Ä–µ–Ω–∏–µ –ø–µ—Ä–µ—á–Ω—è –∂–∏–∑–Ω–µ–Ω–Ω–æ –Ω–µ–æ–±—Ö–æ–¥–∏–º—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö —Å—Ä–µ–¥—Å—Ç–≤ –ø—Ä–∏–∑–Ω–∞–Ω–æ –Ω–µ –ø—Ä–æ—Å—Ç–æ –º–µ—Ä–æ–π –ø–æ–¥–¥–µ—Ä–∂–∫–∏, –∞ –≤–∞–∂–Ω–µ–π—à–∏–º —É—Å–ª–æ–≤–∏–µ–º —Å–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –∫–∞—á–µ—Å—Ç–≤–∞ –∂–∏–∑–Ω–∏ –ª—é–¥–µ–π, –¥–ª—è –∫–æ—Ç–æ—Ä—ã—Ö —Å–æ–≤—Ä–µ–º–µ–Ω–Ω—ã–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã–µ —Å—Ä–µ–¥—Å—Ç–≤–∞ ‚Äì –Ω–µ –ø—Ä–æ—Å—Ç–æ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∞—è –Ω–µ–æ–±—Ö–æ–¥–∏–º–æ—Å—Ç—å.","{
  ""skip"": false,
  ""country"": ""Kazakhstan"",
  ""topic"": ""regulation, reimbursement, shortage"",
  ""impact"": ""high"",
  ""english"": ""The resolution was adopted at an extra session of the Almaty city council to expand the list of diseases and medicines for residents living with rare diseases. The rise in such cases over recent years prompted this discussion. Currently, there are already 4,287 patients with rare diagnoses compared to just 140 in 2017. Therefore, expanding the list of essential medicines is considered not only a supportive measure but also a crucial condition for maintaining the quality of life for people who rely on modern medications.""
}"
2025-12-11T05:57:18+00:00,@pharmnewskz,6586,https://t.me/pharmnewskz/6586,"–ü—Ä–µ–¥—Å–µ–¥–∞—Ç–µ–ª—å –ø—Ä–∞–≤–ª–µ–Ω–∏—è –¢–û–û ¬´–°–ö-–§–∞—Ä–º–∞—Ü–∏—è¬ª –ù—É—Ä–ª—ã–±–µ–∫ –ê—Å—ã–ª–±–µ–∫–æ–≤ –ø—Ä–æ–≤—ë–ª –æ–Ω–ª–∞–π–Ω-–≤—Å—Ç—Ä–µ—á—É —Å —Ä—É–∫–æ–≤–æ–¥—Å—Ç–≤–æ–º –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –ø—Ä–µ–¥–ø—Ä–∏—è—Ç–∏—è ¬´–ö—ã—Ä–≥—ã–∑—Ñ–∞—Ä–º–∞—Ü–∏—è¬ª –¥–ª—è –æ–±—Å—É–∂–¥–µ–Ω–∏—è –º–µ—Ö–∞–Ω–∏–∑–º–æ–≤ —Å–æ–≤–º–µ—Å—Ç–Ω—ã—Ö –∑–∞–∫—É–ø–æ–∫ –ª–µ–∫–∞—Ä—Å—Ç–≤ –∏ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –∏–∑–¥–µ–ª–∏–π. ¬´–ö—ã—Ä–≥—ã–∑—Ñ–∞—Ä–º–∞—Ü–∏—è¬ª, —Å–æ–∑–¥–∞–Ω–Ω–∞—è –≤ 2023 –≥–æ–¥—É –ø—Ä–∏ –ú–∏–Ω–∑–¥—Ä–∞–≤–µ –ö—ã—Ä–≥—ã–∑—Å—Ç–∞–Ω–∞, –æ—Ç–≤–µ—á–∞–µ—Ç –∑–∞ —Ü–µ–Ω—Ç—Ä–∞–ª–∏–∑–æ–≤–∞–Ω–Ω—ã–π –∑–∞–∫—É–ø –º–µ–¥–∏–∫–∞–º–µ–Ω—Ç–æ–≤ –¥–ª—è –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–π –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è. –°—Ç–æ—Ä–æ–Ω—ã –¥–æ–≥–æ–≤–æ—Ä–∏–ª–∏—Å—å –æ –Ω–∞—á–∞–ª–µ –ø–æ–¥–≥–æ—Ç–æ–≤–∫–∏ –∫ –≥—Ä—É–ø–ø–æ–≤—ã–º –∑–∞–∫—É–ø–∫–∞–º —É–∂–µ –≤ 2026 –≥–æ–¥—É, —á—Ç–æ–±—ã –æ–±–µ—Å–ø–µ—á–∏—Ç—å –∏—Ö –∑–∞–ø—É—Å–∫ –≤ 2027-–º. –ü–æ —Å–ª–æ–≤–∞–º –ù—É—Ä–ª—ã–±–µ–∫–∞ –ê—Å—ã–ª–±–µ–∫–æ–≤–∞, –æ–±—ä–µ–¥–∏–Ω–µ–Ω–∏–µ –æ–±—ä—ë–º–æ–≤ –¥–≤—É—Ö —Å—Ç—Ä–∞–Ω –ø–æ–∑–≤–æ–ª–∏—Ç —Ñ–æ—Ä–º–∏—Ä–æ–≤–∞—Ç—å –±–æ–ª–µ–µ –∫—Ä—É–ø–Ω—ã–µ –ª–æ—Ç—ã, —É—Å–∏–ª–∏—Ç—å –ø–µ—Ä–µ–≥–æ–≤–æ—Ä–Ω—É—é –ø–æ–∑–∏—Ü–∏—é, —Å–Ω–∏–∑–∏—Ç—å –∑–∞–∫—É–ø–æ—á–Ω—ã–µ —Ü–µ–Ω—ã –∏ –æ–±–µ—Å–ø–µ—á–∏—Ç—å –±–æ–ª–µ–µ —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ–µ –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏–µ –±—é–¥–∂–µ—Ç–Ω—ã—Ö —Å—Ä–µ–¥—Å—Ç–≤.","{
  ""skip"": false,
  ""country"": ""Kyrgyz Republic"",
  ""topic"": ""tenders, import_export, shortage"",
  ""impact"": ""high"",
  ""english"": ""The Chairman of the Board of TEOO 'SK-Farmacia' Nurlybek Asylbekov held an online meeting with the leadership of the state enterprise 'Kyrgyzafarmacia' to discuss mechanisms for joint purchases of medicines and medical devices. Kyrgyzafarmacia, established in 2023 by the Ministry of Health of Kyrgyzstan, is responsible for centralized procurement of medicines for government healthcare organizations. The sides agreed to start preparations for group purchases as early as 2026 to ensure their launch in 2027. According to Nurlybek Asylbekov, combining the volumes of both countries will allow forming larger lots, strengthening negotiation positions, reducing purchase prices and ensuring more efficient use of budget funds.""
}"
2025-12-11T05:54:10+00:00,@pharmnewskz,6585,https://t.me/pharmnewskz/6585,"–ö–∞–∫ —Å–æ–æ–±—â–∞–µ—Ç –ø—Ä–µ—Å—Å-—Å–ª—É–∂–±–∞ –ú–∏–Ω–∑–¥—Ä–∞–≤–∞, –≤ 2025 –≥–æ–¥—É –ö–∞–∑–∞—Ö—Å—Ç–∞–Ω –∑–Ω–∞—á–∏—Ç–µ–ª—å–Ω–æ —Ä–∞—Å—à–∏—Ä–∏–ª –¥–æ—Å—Ç—É–ø–Ω–æ—Å—Ç—å –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π —Ä–µ–∞–±–∏–ª–∏—Ç–∞—Ü–∏–∏ –¥–ª—è –¥–µ—Ç–µ–π. –í —Ä–∞–º–∫–∞—Ö –ø—Ä–æ–µ–∫—Ç–∞ ¬´“ö–∞–º“õ–æ—Ä–ª—ã“õ¬ª –æ—Ç–∫—Ä—ã—Ç–æ 6 –Ω–æ–≤—ã—Ö –º–µ–∂—Ä–∞–π–æ–Ω–Ω—ã—Ö —Ä–µ–∞–±–∏–ª–∏—Ç–∞—Ü–∏–æ–Ω–Ω—ã—Ö —Ü–µ–Ω—Ç—Ä–æ–≤ –≤ –ê—Ç—ã—Ä–∞—É—Å–∫–æ–π, –ö—ã–∑—ã–ª–æ—Ä–¥–∏–Ω—Å–∫–æ–π, –ê–ª–º–∞—Ç–∏–Ω—Å–∫–æ–π, –ú–∞–Ω–≥–∏—Å—Ç–∞—É—Å–∫–æ–π, –ñ–µ—Ç—ã—Å—É –∏ –ê–∫–º–æ–ª–∏–Ω—Å–∫–æ–π –æ–±–ª–∞—Å—Ç—è—Ö. –í—Å–µ–≥–æ –≤ —Ç–µ–∫—É—â–µ–º –≥–æ–¥—É —Ä–µ–∞–±–∏–ª–∏—Ç–∞—Ü–∏–æ–Ω–Ω—É—é –ø–æ–º–æ—â—å –ø–æ–ª—É—á–∏–ª–∏ 125 —Ç—ã—Å—è—á –¥–µ—Ç–µ–π. –û–¥–Ω–æ–≤—Ä–µ–º–µ–Ω–Ω–æ –≤–µ–¥–µ—Ç—Å—è —Å–∏—Å—Ç–µ–º–Ω–∞—è —Ä–∞–±–æ—Ç–∞ –ø–æ —Ä–∞–∑–≤–∏—Ç–∏—é —Å–ø–µ—Ü–∏–∞–ª–∏–∑–∏—Ä–æ–≤–∞–Ω–Ω—ã—Ö –ø—Ä–æ–≥—Ä–∞–º–º –≤ —Å—Ñ–µ—Ä–µ –¥–µ—Ç—Å–∫–æ–≥–æ –∑–¥–æ—Ä–æ–≤—å—è. –í —Å—Ç—Ä–∞–Ω–µ —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–Ω–∞ –ö–æ–Ω—Ü–µ–ø—Ü–∏—è –µ–¥–∏–Ω–æ–π –ø—Ä–æ–≥—Ä–∞–º–º—ã ¬´–î–µ—Ç–∏ –ö–∞–∑–∞—Ö—Å—Ç–∞–Ω–∞¬ª –∏ –ø–ª–∞–Ω –¥–µ–π—Å—Ç–≤–∏–π –Ω–∞ 2026-2030 –≥–æ–¥—ã. –î–æ–∫—É–º–µ–Ω—Ç –æ–±—ä–µ–¥–∏–Ω—è–µ—Ç –≤—Å–µ –¥–µ–π—Å—Ç–≤—É—é—â–∏–µ –∏ –ø–ª–∞–Ω–∏—Ä—É–µ–º—ã–µ –º–µ—Ä—ã, –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω–Ω—ã–µ –Ω–∞ –æ–±–µ—Å–ø–µ—á–µ–Ω–∏–µ –ø—Ä–∞–≤ –∏ –±–ª–∞–≥–æ–ø–æ–ª—É—á–∏—è –∫–∞–∂–¥–æ–≥–æ —Ä–µ–±–µ–Ω–∫–∞. –≠—Ç–æ –ø–µ—Ä–≤–∞—è –≤ –ö–∞–∑–∞—Ö—Å—Ç–∞–Ω–µ –∫–æ–º–ø–ª–µ–∫—Å–Ω–∞—è –ø—Ä–æ–≥—Ä–∞–º–º–∞, –æ–±—ä–µ–¥–∏–Ω—è—é—â–∞—è —É—Å–∏–ª–∏—è –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–∞, —Ä–æ–¥–∏—Ç–µ–ª–µ–π, –ø–µ–¥–∞–≥–æ–≥–æ–≤, –≤—Ä–∞—á–µ–π, —Å–æ—Ü–∏–∞–ª—å–Ω—ã—Ö —Å–ª—É–∂–± –∏ –ù–ü–û.","{
  ""skip"": false,
  ""country"": ""Kazakhstan"",
  ""topic"": ""regulation, registration, reimbursement"",
  ""impact"": ""high"",
  ""english"": ""The Ministry of Health reported that in 2025 Kazakhstan significantly expanded access to medical rehabilitation for children. As part of the 'Qamqorlyk' project, six new inter-county rehabilitation centers were opened in Atyrau, Qyzylorda, Almaty, Mangistau, Jetyussu and Aktau regions. In total, 125 thousand children received rehabilitation assistance this year. At the same time, systematic work is being carried out to develop specialized programs in the field of pediatric health. The country has developed a Conceptual Program 'Children of Kazakhstan' and a plan for actions from 2026-2030 years. The document integrates all existing and planned measures aimed at ensuring rights and well-being of each child. This is the first comprehensive program in Kazakhstan, integrating state efforts, parents, teachers, doctors, social services, and NGOs.""
}"
2025-12-11T05:52:25+00:00,@pharmnewskz,6584,https://t.me/pharmnewskz/6584,"–£–ø—Ä–∞–≤–ª–µ–Ω–∏–µ –ø–æ –∫–æ–Ω—Ç—Ä–æ–ª—é –∫–∞—á–µ—Å—Ç–≤–∞ –ø–∏—â–µ–≤—ã—Ö –ø—Ä–æ–¥—É–∫—Ç–æ–≤ –∏ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö —Å—Ä–µ–¥—Å—Ç–≤ –°–®–ê (FDA) —É–≤–µ–¥–æ–º–∏–ª–æ –∫–æ–º–ø–∞–Ω–∏–∏ MSD, Sanofi –∏ AstraZeneca –æ –ø—Ä–µ–¥—Å—Ç–æ—è—â–µ–π –ø—Ä–æ–≤–µ—Ä–∫–µ –≤–∞–∫—Ü–∏–Ω –¥–ª—è –º–ª–∞–¥–µ–Ω—Ü–µ–≤ –≤ —Å–≤—è–∑–∏ —Å –æ–ø–∞—Å–µ–Ω–∏—è–º–∏, –≤—ã—Å–∫–∞–∑–∞–Ω–Ω—ã–º–∏ —Å—Ç–æ—Ä–æ–Ω–Ω–∏–∫–∞–º–∏ –∞–Ω—Ç–∏–ø—Ä–∏–≤–∏–≤–æ—á–Ω–æ–≥–æ –¥–≤–∏–∂–µ–Ω–∏—è. –û—Å–æ–±–æ–µ –≤–Ω–∏–º–∞–Ω–∏–µ –º–∏–Ω–∏—Å—Ç—Ä –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –°–®–ê –†–æ–±–µ—Ä—Ç –§. –ö–µ–Ω–Ω–µ–¥–∏-–º–ª–∞–¥—à–∏–π, –∏–∑–≤–µ—Å—Ç–Ω—ã–π —Å–≤–æ–∏–º–∏ –∫—Ä–∏—Ç–∏—á–µ—Å–∫–∏–º–∏ –≤–∑–≥–ª—è–¥–∞–º–∏ –Ω–∞ –≤–∞–∫—Ü–∏–Ω–∞—Ü–∏—é, –æ–±—Ä–∞—Ç–∏–ª –Ω–∞ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã Beyfortus –æ—Ç Sanofi/AstraZeneca –∏ Enflonsia –æ—Ç MSD. –ü–æ –º–Ω–µ–Ω–∏—é –ö–µ–Ω–Ω–µ–¥–∏, –ø–æ—Ç–µ–Ω—Ü–∏–∞–ª—å–Ω—ã–µ —Ä–∏—Å–∫–∏ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏—è —Ä—è–¥–∞ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –±—ã–ª–∏ –∏–∑—É—á–µ–Ω—ã –Ω–µ–¥–æ—Å—Ç–∞—Ç–æ—á–Ω–æ. –í–µ–¥—É—â–∏–µ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–µ —Å–æ–æ–±—â–µ—Å—Ç–≤–∞ –∏ –æ—Ñ–∏—Ü–∏–∞–ª—å–Ω—ã–µ –ø—Ä–µ–¥—Å—Ç–∞–≤–∏—Ç–µ–ª–∏ —Å–ª—É–∂–± –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –æ–±–≤–∏–Ω—è—é—Ç –ö–µ–Ω–Ω–µ–¥–∏ –≤ –ø–æ–ø—ã—Ç–∫–µ —Å–≤–µ—Ä–Ω—É—Ç—å –ø—Ä–æ–≥—Ä–∞–º–º—É –≤–∞–∫—Ü–∏–Ω–∞—Ü–∏–∏. –ü–æ –∏—Ö —Å–ª–æ–≤–∞–º, –º–∏–Ω–∏—Å—Ç—Ä —Ä—É–∫–æ–≤–æ–¥—Å—Ç–≤—É–µ—Ç—Å—è –ª–∏—á–Ω—ã–º–∏ —É–±–µ–∂–¥–µ–Ω–∏—è–º–∏, –∞ –Ω–µ –Ω–∞—É—á–Ω—ã–º–∏ –¥–∞–Ω–Ω—ã–º–∏.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""sanctions, vaccine"",
  ""impact"": ""high"",
  ""english"": ""The FDA notified MSD, Sanofi, and AstraZeneca about an upcoming inspection of vaccines for infants due to concerns raised by anti-vaccination activists. Robert F. Kennedy Jr., known for his critical views on vaccination, highlighted the drugs Beyfortus from Sanofi/AstraZeneca and Enflonsia from MSD. Kennedy believes that potential risks associated with several medications were not sufficiently studied. Leading medical communities and official health service representatives accused Kennedy of trying to dismantle the vaccination program. They argue that he is guided by personal beliefs rather than scientific data.""
}"
2025-12-11T08:05:40+00:00,@rncpharma,611,https://t.me/rncpharma/611,"üí≠ –í –†–æ—Å—Å–∏–∏ –∞–∫—Ç–∏–≤–∏–∑–∏—Ä–æ–≤–∞–ª—Å—è —Å–ø—Ä–æ—Å –Ω–∞ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–µ –∫–∏—Å–ª–æ—Ä–æ–¥–Ω—ã–µ –∫–æ–Ω—Ü–µ–Ω—Ç—Ä–∞—Ç–æ—Ä—ã, –¥–∏–Ω–∞–º–∏–∫–∞ –≤—Ç–æ—Ä–æ–π –≥–æ–¥ –ø–æ–¥—Ä—è–¥ –ø—Ä–µ–≤—ã—à–∞–µ—Ç 40% –ü–æ –¥–∞–Ω–Ω—ã–º RNC Pharma –≤ —è–Ω–≤–∞—Ä–µ-–æ–∫—Ç—è–±—Ä–µ 2025 –≥.: üìà 867,0 –º–ª–Ω —Ä—É–±–ª–µ–π —Å–æ—Å—Ç–∞–≤–∏–ª –æ–±—ä–µ–º –ø—Ä–æ–¥–∞–∂ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –∫–∏—Å–ª–æ—Ä–æ–¥–Ω—ã—Ö –∫–æ–Ω—Ü–µ–Ω—Ç—Ä–∞—Ç–æ—Ä–æ–≤ –Ω–∞ —Ä–æ—Å—Å–∏–π—Å–∫–æ–º —Ä–æ–∑–Ω–∏—á–Ω–æ–º —Ä—ã–Ω–∫–µ, –≤–∫–ª—é—á–∞—è –º–∞—Ä–∫–µ—Ç–ø–ª–µ–π—Å—ã –∏ FMCG (+19% –∫ —è–Ω–≤-–æ–∫—Ç ‚Äô24) üìà 40,8 —Ç—ã—Å. –ø—Ä–∏–±–æ—Ä–æ–≤ –±—ã–ª–æ –ø—Ä–æ–¥–∞–Ω–æ (+47% –∫ —è–Ω–≤-–æ–∫—Ç ‚Äô24) üìä 21,2 —Ç—ã—Å. —Ä—É–±–ª–µ–π —Å–æ—Å—Ç–∞–≤–∏–ª–∞ —Å—Ä–µ–¥–Ω—è—è —Å—Ç–æ–∏–º–æ—Å—Ç—å –ø—Ä–∏–±–æ—Ä–∞, –ø—Ä–∏ —ç—Ç–æ–º —Å—Ç–æ–∏–º–æ—Å—Ç—å –≤ —Ä–æ–∑–Ω–∏—Ü–µ –≤–∞—Ä—å–∏—Ä—É–µ—Ç –æ—Ç 12-15 —Ç—ã—Å. —Ä—É–±. –¥–æ 200-250 —Ç—ã—Å. —Ä—É–±. –ö–∞–Ω–∞–ª—ã –ø—Ä–æ–¥–∞–∂ üîÉ ‚û°Ô∏è –ú–∞—Ä–∫–µ—Ç–ø–ª–µ–π—Å—ã: –¥–æ–ª—è –∫–∞–Ω–∞–ª–∞ —Å–æ—Å—Ç–∞–≤–ª—è–µ—Ç 86% –≤ —à—Ç. –∏ 72% –≤ —Ä—É–±. –õ–∏–¥–µ—Ä—ã: ¬´–û–∑–æ–Ω¬ª,¬´–í–∞–π–ª–¥–±–µ—Ä—Ä–∏–∑¬ª ‚û°Ô∏è FMCG-—Ä–∏—Ç–µ–π–ª: 13% –≤ —à—Ç. –∏ 27% –≤ —Ä—É–±. ‚û°Ô∏è –ê–ø—Ç–µ–∫–∏: 1% –≤ —à—Ç. –∏ –≤ —Ä—É–±. –ë–æ–ª—å—à–µ –¥–∞–Ω–Ω—ã—Ö #–º–µ–¥—Ç–µ—Ö–Ω–∏–∫–∞ #ecom ‚ö™Ô∏è –ü–æ–¥–ø–∏—Å–∞—Ç—å—Å—è –Ω–∞ RNC Pharma | ‚úâÔ∏è –ó–∞–∫–∞–∑–∞—Ç—å –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–µ","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""demand, shortage, clinical_trial"",
  ""impact"": ""high"",
  ""english"": ""There has been a significant increase in demand for medical oxygen concentrators in Russia. Sales data from January to October 2025 show that the total retail sales volume (including marketplaces and FMCG) reached 867 million rubles, up by 19% compared to the same period last year. The number of devices sold increased by 47%, reaching 40,800 units. The average price per device is around 21,200 rubles, with prices ranging from 12-15 thousand rubles to 200-250 thousand rubles. Sales channels: marketplaces (86% in quantity and 72% in value), FMCG retail (13%), pharmacies (1%).""
}"
